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ABSTRACT  
 
Axons allow neurons to communicate over long distances, however their long length 
makes them vulnerable to injury, since damage at any location leads to loss of a neuron’s 
function within a circuit. Repair from axonal damage requires that damaged axon gains an ability 
to initiate new growth which is termed axonal regeneration. This involves the activation of 
signaling pathways in the injured neurons which promote a ‘regenerative’ state, but many 
neuronal types in the mammalian central nervous system show a failure to initiate this state. 
Functional repair also requires that the distal axonal stumps, which have lost connection with cell 
bodies hence are non-functional, undergo degeneration and clearance via a process termed 
Wallerian degeneration. This degeneration takes place via a cell autonomous self-destructive 
pathway, akin to apoptosis, but with distinct, and still poorly characterized molecular 
components.  
My thesis work has focused on understanding the cellular mechanisms by which neurons 
detect and respond to axonal damage. A conserved axonal kinase, named DLK in mammals or 
Wallenda (Wnd) in Drosophila, appears to function as a ‘sensor’ of axonal damage in neurons.  
However, the mechanism that activates Wnd/DLK is unknown. I have discovered that the 
cAMP-regulated protein kinase A (PKA) is a conserved and direct upstream activator of 
Wnd/DLK: PKA is required for the induction of Wnd/DLK signaling in injured axons, and 
directly stimulates its activation via phosphorylation of its activation loop. Elevation of 
intracellular cAMP level is a broadly known but poorly understood method to stimulate the 
growth potential of axons. In this study, I found that DLK is essential for the regenerative effects 
 xvi 
 
of cAMP. These findings link two important mediators, DLK/Wnd and cAMP/PKA, into a 
unified and evolutionarily conserved molecular pathway for regulating axonal regeneration upon 
axonal injury.   
My work has also identified a new regulator of Wallerian degeneration, from the 
fortuitous discovery of a mutation that strongly inhibited axonal degeneration in the strain 
background of dcp-1 mutant. Genetic mapping, whole genome sequencing and rescue analysis 
pinpoint this phenotype to a mutation in the putative transmembrane protein, Raw. Raw 
functions as a negative regulator of the transcription factor AP-1, and this activity mediates its 
role in axonal degeneration. While Raw does not have an obvious mammalian homologue, the 
basic mechanism of axonal degeneration is highly conserved between Drosophila and 
mammalian neurons, so understanding the mechanism for Raw in degeneration may lead to new 
insight for understanding and treating nerve damage in humans.  
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Chapter 1 :  
Introduction 
 
1.1 Abstract 
Axons connect neurons over long distances in the brain and body, and because of this are 
vulnerable to damage and injury. In some cases, damaged axons can initiate new growth and 
reconnect with their targets. However, in cases such as in the mammalian central nervous system 
(CNS), damaged axons fail to regrow and the disconnected neurons undergo cell death.  Both 
regeneration and cell death involve a large-scale transcriptional response of the neuron to a 
signal that is, in most cases, far away from the cell body.  How does the cell body ‘know’ that a 
distant site in the axon is injured? In this thesis work, I seek to understand the fundamental 
question of how neurons sense and cope with the axonal damage. Understanding the mechanisms 
of neuronal injury response is of great interest as it will shed light on the development of 
strategies to repair neuronal damage after injury. In this chapter of my dissertation, I will give a 
general introduction to how neurons response to axonal injuries and initiate regenerative growth. 
The first part of this chapter will focus on mechanisms that promote axonal regeneration after 
injury, with particular emphasis on the known signaling pathways that are involved.  The second 
part of this chapter will focus on one crucial and evolutionarily conserved signaling cascade 
which senses and coordinates responses to axonal damage.  A central regulator of this pathway is 
an axonal mitogen activated protein kinase kinase kinase (MAPKKK), which is named Wallenda 
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(Wnd) in Drosophila or Dual Leucine Zipper Kinase (DLK) in mammals. I will review 
regulatory mechanisms of Wnd/DLK, which are the focus of my thesis work. The novel 
mechanism of DLK regulation and its functional consequences that I discovered will be 
described in the following chapters of the dissertation. The third part of this chapter will focus on 
the mechanisms of axonal degeneration.  
1.2 Axonal injury signaling and regeneration  
Neurons are post mitotic cells with axons that transmit information over long distances.  
Therefore, failure of repair after axonal injury results in permanent functional deficits. There is a 
dichotomy in the ability of the nervous system to undergo repair between peripheral nervous 
system (PNS) and the central nervous system (CNS). In the PNS, the injured axon is able to 
initiate new axonal growth and the newly grown axon can reach and ultimately reconnect with its 
original target. This form of repair is referred to as ‘axon regeneration’.  However, axon 
regeneration generally fails to occur in many cases, including in the adult mammalian CNS.   
Hence, understanding the cellular mechanisms of injury response can provide potential strategies 
for stimulating axon regeneration and even functional recovery after CNS injury.   
1.2.1 Extrinsic and intrinsic factors for axon regeneration 
The dichotomy between the regenerative capacity of the CNS and the PNS inspires much 
interest in understanding the differences between them.  Injury of axons in the PNS induces 
large-scale transcriptional-dependent responses in gene expression and axonal transport that 
promote effective growth by enhancing the intrinsic regenerative state.  A key observation that 
injured CNS axons were able to regenerate in the PNS environment (Richardson and Issa, 1984) 
suggested that the growth environment might also play a role in axon regeneration.  Indeed, it is 
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now widely accepted that both intrinsic and extrinsic factors contribute to the axon regeneration 
in the CNS.   
One major environmental distinction between the PNS and the CNS is the composition of 
the myelin sheath.  While axons in the PNS are wrapped by Schwann cells, axons in the CNS are 
myelinated by oligodendrocytes. Multiple ligands and receptors are involved in the inhibition of 
axon growth by affecting cytoskeleton rearrangements through a signaling pathway that involves 
Rho and Rho-associated kinase (ROCK) (Wills et al., 2012, Domeniconi et al., 2005).  MAG, 
OMgp and Nogo are three prototypical CNS myelin-associated axon regeneration inhibitors that 
have been studied extensively during the past few decades.  MAG is a transmembrane 
glycoprotein that functions as an age-dependent switch in certain neuronal types: it promotes 
axon growth during neuronal development and inhibits axon growth once the axon is mature 
(Mukhopadhyay et al., 1994).  OMgp is a glycosylphosphatidylinositol (GPI)-anchored protein 
which is involved in the regulation of synaptic plasticity (Raiker et al., 2010). Nogo has three 
isoforms (Nogo-A, Nogo-B and Nogo-C), among which Nogo-A is expressed most abundantly 
in oligodendrocytes (Huber et al., 2002). Nogo-A is a transmembrane protein that is expressed in 
endoplasmic reticulum and cell surface.  Multiple Nogo knockout mice lines all exhibit reduced 
inhibitory effects on neurite growth (Lee and Zheng, 2012). These three ligands share some of 
the receptors including NgRs and PirB (Geoffroy and Zheng, 2014). However, genetic studies 
targeting one or even multiple of these inhibitors and receptors demonstrate very limited effects 
on axon regeneration in CNS (Geoffroy and Zheng, 2014).   
In addition to myelin-associated inhibitors, another major deterrent to axon regeneration 
is the glial scar, which forms at the injury site after the CNS injury. The scar is composed of 
astrocytes, oligodendrocytes precursors, microglia, meningeal cells and stem cells (Fawcett and 
 4 
 
Asher, 1999).  Reactive astrocytes in the glial scar generate many inhibitory molecules in scar 
extracellular matrix, such as tenascins, semaphorin 3A and chondroitin sulfate proteoglycans 
(CSPGs) (Sandvig et al., 2004). Among them, CSPGs are of great importance as they are 
dramatically increased in scar tissue in CNS after injury (Galtrey and Fawcett, 2007).  They 
specifically bind to and activate functional receptors including leukocyte common antigen-
related (LAR) phosphatase (Fisher et al., 2011) and NgRs (Dickendesher et al., 2012), suggesting 
they might share similar signaling pathways with myelin-associated inhibitors.  Moreover, these 
large molecules concentrate and form non-permissive perineuronal nets that physically prevent 
axons from regenerating (Ohtake and Li, 2015).  Therefore, CSPGs inhibit axon regeneration 
through several different mechanisms, making them extremely difficult to target therapeutically.  
In addition, some studies suggest that the lack of supportive growth factors (Gordon, 2009, 
Harvey et al., 2012) and persistent inflammation (Donnelly and Popovich, 2008, Benowitz and 
Popovich, 2011) also contribute to the extracellular inhibitory environment for axon regeneration.  
To sustain axonal growth over long distances, a cell body response appears to be 
indispensable in both the PNS and the CNS. A cell body needs to coordinate the raw material 
synthesis and transportation to the injury site.  Thus, the cellular intrinsic pathways that are 
activated by axonal injury are of great importance.  I will discuss the known signaling pathways 
involved in injury response in details (section 1.1.3) after introduction of ‘conditioning lesion’ 
(section 1.1.2).  
1.2.2 Conditioning lesion and regeneration 
The conditioning lesion experiment of primary mammalian adult sensory neurons from 
dorsal root ganglion (DRG) has been a classic model to study the intrinsic mechanism of axon 
regeneration.  DRG neurons are unique as they have two axonal branches, one extends to the 
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PNS and the other projects to the CNS.  Richardson and Issa first discovered that the central 
branches of DRGs could regenerate in a peripheral nerve graft if the peripheral branch has been 
previously injured (called a conditioning lesion) (Richardson and Issa, 1984).  Then Neumann 
and Woolf demonstrated that both central and peripheral branches could regenerate robustly, as 
long as the conditioning lesion is carried out in the peripheral branch (Neumann and Woolf, 
1999). In addition, more recent study suggests that a PNS injury that is induced after the CNS 
injury is still sufficient to promote axon regeneration in the CNS (Ylera et al., 2009). Therefore, 
it is of great interest from a therapeutic perspective to understand the molecular mechanisms by 
which such regenerative potential can be released.  
Injuries in PNS axons trigger transcriptional changes in many genes, including 
transcription factors (such as ATF-3, c-Jun and Sox11), Arginase 1 (a key enzyme in polyamine 
synthesis), translation regulators, actin and tubulins (reviewed by (Ma and Willis, 2015)). In 
contrast, there are only minor changes of gene transcription after injury in the CNS (Mason et al., 
2002, Starkey et al., 2009, Schreyer and Skene, 1993, Geeven et al., 2011). It is unknown why 
the changes in gene expression are different. However, it is well known that genetic 
manipulations such as PTEN deletion (Park et al., 2008, Sun et al., 2011) or elevation of 
intracellular cyclic adenosine monophosphate (cAMP) (Neumann et al., 2002, Cai et al., 1999, 
Gao et al., 2003) strongly promote axon regeneration in the CNS. Therefore, understanding the 
intrinsic cellular pathways that are stimulated by the conditioning lesion in the PNS could shed 
light on the therapeutic strategies for CNS injuries.  
1.2.3 Intrinsic axonal injury signaling pathways 
Robust axon regeneration in the PNS is associated with the broad activation of gene 
transcription and other molecular changes in the cell body (Blackmore, 2012), suggesting that 
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injury induces complex reactions in neurons.  What are the core upstream signaling pathways 
that coordinate transcriptional programs and stimulate axon regeneration?  This section will 
review the central signaling pathways, including recent discoveries, in different model organisms.  
1.2.3.1 JNK/c-Jun pathway  
Transcription factor c-Jun is activated by axonal injury and required for axon 
regeneration (Raivich et al., 2004).  c-Jun is phosphorylated and activated by a mitogen-activated 
protein kinase (MAPK) called c-Jun N-terminal kinase (JNK).  Previous studies have suggested 
that JNK can be locally activated in axon by injuries and retrogradely transported to the cell body 
(Lindwall and Kanje, 2005, Cavalli et al., 2005). In support of this, JNK is found to be linked to 
the motor protein dynein by the scaffolding protein JIP3 (Sunday driver in Drosophila) (Cavalli 
et al., 2005).   
1.2.3.2 JAK/STAT pathway 
Many studies have been focusing on inflammation responses which are demonstrated to 
be beneficial to axon regeneration (Richardson and Lu, 1994).  For example, gp130 cytokines 
(leukemia inhibitory factor, LIF and interleukin-6, IL-6) knockout mice show reduced axon 
regeneration after injury (Zhong et al., 1999, Cafferty et al., 2004).  Recent studies showed that 
overexpression of a monocyte chemokine CCL2 in DRG neurons promotes neurite growth 
(Niemi et al., 2016, Kwon et al., 2015). Both gp130 cytokines and CCL2 function through the 
downstream Janus kinase (JAK)-signal transducer and activator of transcription (STAT) 
signaling pathway (Niemi et al., 2016, Shuai and Liu, 2003). The JAK-STAT pathway can be 
activated acutely by peripheral axon injuries and is essential for the conditioning injury effects in 
vivo (Qiu et al., 2005).    
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The suppressor of cytokine signaling 3 (SOCS3) is a negative regulator of the JAK-
STAT pathway (Baker et al., 2009). Smith et al. showed that deletion of SOCS3 strongly 
enhanced axon regeneration in retinal ganglion cells (RGCs) in vivo (Smith et al., 2009).  
However, no axon regeneration is observed in SOCS3 and gp130 double deletion RGCs, 
suggesting that gp130 cytokines are essential for axon regeneration in SOCS3 mutants (Smith et 
al., 2009).   
1.2.3.3 PTEN/mTOR  
To prevent neurons from overgrowth when they are mature, several growth inhibitory 
pathways are engaged, including the tumor suppressor phosphatase and tensin homolog 
(PTEN)/mTOR pathway. Does axon regeneration require a re-activation of the growth program?  
To answer this question, Park et al. did a candidate-based genetic screen in RGCs and found that 
deletion of the gene PTEN promoted robust axon regeneration (Park et al., 2008).  PTEN is a 
phosphatase that converts PIP3 to PIP2. Deletion of PTEN leads to accumulation of PIP3 which 
can activate AKT. mTOR is one of the downstream targets of AKT. Application of rapamycin, a 
mTOR inhibitor, abolishes the regeneration effects (Park et al., 2008), indicating that the 
enhanced axon regeneration in PTEN mutants is mTOR dependent. Indeed, axotomy triggers a 
stress response in which mTOR levels are significantly reduced in RGCs (Park et al., 2008). As a 
central regulator of protein translation, mTOR down-regulation could be the mechanism by 
which axon regeneration fails in the CNS. However, it is unknown that whether or not this is the 
only reason.  
1.2.3.4 Newly identified axon regeneration regulators: Hif-1α and Activin 
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A recent study has identified that hypoxia-inducible factor 1α (HIF-1α) positively 
regulates axon regeneration and contributes to preconditioning lesion effects (Cho et al., 2015).  
HIF-1α is activated by hypoxia and controls multiple injury-induced gene expression (Cho et al., 
2015). Therefore, hypoxia could be a new tool to treat axonal injuries.  
Another research group found axons regenerate significantly better in a specific mice line 
CAST/Ei (Omura et al., 2015). Omura et al. performed a whole-genome expression screen and 
found gene Activin is highly correlated with axon regeneration ability (Omura et al., 2015).  
However, the underlying molecular mechanisms need further investigation.  
1.2.3.5 svh-1/svh-2 in C.elegans 
In C.elegans, the growth factor svh-1 and its corresponding receptor tyrosine kinase svh-
2 were identified to be upstream regulators of the JNK/c-Jun pathway that regulates axon 
regeneration (Li et al., 2012).  The svh-2 expression level is induced by axonal injuries (Li et al., 
2012).  Svh-1 does not have an obvious homolog in mammals, but based on structural analysis, it 
belongs to the hepatocyte growth factor (HGF), macrophage stimulating protein (MSP) and 
plasminogen super family.  Svh-2 is homologous to the HGF receptor Ron in mammals.  A 
recent study suggested that svh-2 expression is regulated by transcription factors ETS-4 and 
CEBP-1, both of which are activated by axonal injuries (Li et al., 2015).  However, this pathway 
has not yet been studied in mammals.  
1.2.3.6 RNA splicing/repair pathway 
Song et al. used Drosophila as a model organism and identified the RNA 3’-terminal 
phosphate cyclase (Rtca) as an inhibitor of axon regeneration (Song et al., 2015).  Rtca is an 
RNA processing enzyme whose function is not fully understood.  Interestingly, another 
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independent study in C.elegans found that RtcB, an RNA ligase, inhibits axon regeneration 
(Kosmaczewski et al., 2015).  RtcB is involved in the processing of the mRNA of the 
transcription factor Xbp-1, which can activate the unfolded protein response (UPR) 
(Kosmaczewski et al., 2014).  Importantly, a previous study suggested that Xbp-1 is induced by 
optical nerve injury in RGCs and ectopic activation of Xbp-1 promotes axon regeneration (Hu et 
al., 2012).  Therefore, neurons might adopt the RNA processing and repair pathway to cope with 
axonal injuries.  
1.2.3.7 cAMP signaling pathway 
It has been known for a long time that cAMP plays an important role in axon 
regeneration.  The Filbin group was the first to show that elevated level of cAMP enhances axon 
regeneration ability in a variety of mammalian neurons, including DRG neurons growing on 
inhibitory MAG (Cai et al., 1999, Cai et al., 2001). Followed by Neumann et al., they showed 
that increased cAMP level promotes axon regeneration in the mouse CNS in vivo (Neumann et 
al., 2002).  Neumann et al. demonstrated that injection of membrane permeable cAMP into DRG 
neurons can mimic the pre-conditioning effects of peripheral nerve injury (Neumann et al., 2002), 
suggesting that manipulation of intracellular cAMP level could be a potential therapeutic method 
in clinic.  Moreover, a recent study, using zebrafish as a model, demonstrated an optogenetic 
method that can precisely increase cellular cAMP level and stimulate axon regeneration in vivo 
(Xiao et al., 2015b).  
The Filbin group also dissected the underlying molecular mechanism by identifying the 
transcription factor cAMP response element binding protein (CREB) as a downstream factor 
(Gao et al., 2004).  Their research has suggested that constitutively activated CREB in injured 
axons is sufficient to overcome the inhibitory myelin environment in vivo (Gao et al., 2004).  
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They also reported that the level Arginase I (ArgI), a key enzyme in the polyamine synthesis, is 
highly correlated with the activation of CREB (Gao et al., 2004).  Interestingly, a recent study 
suggests that cAMP’s effects on axon regeneration is transcriptional complex activator protein 1 
(AP-1) dependent.  Moreover, AP-1 directly binds to the promoter region of ArgI gene and 
enhances ArgI expression (Ma et al., 2014).  Therefore, multiple molecular mechanisms could 
contribute to the effects of cAMP on axon regeneration.  
My thesis work has identified a novel mechanism for cAMP to promote axon 
regeneration (discussed in detail in Chapter 3).  This mechanism involves activation of a stress-
responding MAPKKK kinase, which is called dual leucine zipper kinase (DLK).  DLK is 
strongly required for axon regeneration in multiple model organisms (Xiong et al., 2010, Shin et 
al., 2012a, Hammarlund et al., 2009, Yan et al., 2009). Apart from that, DLK also plays multiple 
roles in other important cellular processes, which are reviewed in next section (section 2).  
1.3 DLK/Wnd signaling pathway 
DLK, which is named Wallenda (Wnd) in Drosophila, is a neuronal-enriched MAPKKK 
that controls multiple fundamental cellular processes, including cell death, axon degeneration 
and axon regeneration.  How does a kinase regulate these seemingly contradictory processes?  
This section will review the known functions of DLK with specific emphasis on the regulation of 
DLK signaling, which is the interest of my thesis research.  
1.3.1 The Hiw/Wnd signaling pathway plays an important role in synaptic development. 
The function of neuronal circuits relies on the assembly of synapses, which include both 
pre-synaptic terminals and post-synaptic structures.  The size of the pre-synaptic structure is 
crucial for determining the amount of neurotransmitter release and the development of post-
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synaptic structures.  Previous studies have identified an evolutionarily conserved E3 ubiquitin 
ligase, which is named Highwire (Hiw) in Drosophila, in regulating pre-synaptic structures.  
Mutations of hiw in flies lead to dramatic pre-synaptic overgrowth (Wan et al., 2000).  Hiw 
homologs in C.elegans (Rpm-1), zebrafish (Esrom) and mice (Phr1) all have similar functions in 
regulating axon guidance and synaptogenesis (Bloom et al., 2007, Lewcock et al., 2007, Zhen et 
al., 2000, D'Souza et al., 2005).   
In an effort to identify suppressors of the synaptic overgrowth phenotype in Hiw mutants, 
Collins et al. designed a genetic screen in Drosophila and found mutations in wnd can suppress 
the synaptic overgrowth, indicating that Wnd is a target of Hiw (Collins et al., 2006).  Hiw plays 
an important role in keeping Wnd level low in axons to ensure proper synaptic development, as 
overexpression of Wnd in neurons phenocopies the synaptic defects in Hiw mutants (Collins et 
al., 2006).  Studies in C.elegans have suggested that Hiw regulates Wnd level by promoting its 
ubiquitination via the RING domain of Hiw (Nakata et al., 2005).  However, other studies 
indicate that the regulation mechanisms could be more complicated (Bloom et al., 2007, 
Lewcock et al., 2007, DiAntonio et al., 2001).  
1.3.2 DLK mediates both cell death and axon regeneration after injury 
The MAP kinase pathways in cells are organized as cascades: including MAP Kinase 
Kinase Kinases (MAPKKK), which phosphorylate MAP Kinase Kinases (MAPKK) which 
phosphorylate MAP Kinases.  These pathways regulate a myriad of important cellular processes, 
including cell differentiation, cell proliferation, cell survival, mitosis, apoptosis and wound 
healing.  DLK and its downstream factors, MKK4/7 (MAPKK) and JNK (MAPK), function as a 
stress response pathway.  In response to nerve growth factor (NGF) withdrawal or axotomy, the 
DLK/JNK signaling cascade leads to rapid cell death and axon degeneration both in vitro and in 
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vivo (Ghosh et al., 2011, Itoh et al., 2011, Miller et al., 2009).  Moreover, DLK has been 
identified as a key mediator of retinal ganglion cells (RGC) death in glaucoma model (Welsbie et 
al., 2013) and excitotoxicity-induced neuronal degeneration (Pozniak et al., 2013).  DLK is also 
involved in DRG neuron and motoneuron apoptosis, neuronal migration and axon path-finding 
during development (Ghosh et al., 2011, Itoh et al., 2011, Hirai et al., 2006).   
Interestingly, recent studies in diverse model systems suggest that DLK/Wnd plays a key 
role in axon regeneration.  DLK homologous in C.elegans (DLK-1) and Drosophila (Wnd) have 
been shown to regulate axon regeneration after axotomy (Yan et al., 2009, Xiong et al., 2010, 
Hammarlund et al., 2009).  Importantly, Shin et al. has demonstrated that DLK is required for the 
conditioning lesion effects in mouse sciatic nerves (Shin et al., 2012a).  In addition, DLK is also 
crucial for axon regeneration in CNS neurons where regeneration can be ectopically induced by 
mutations on PTEN (Watkins et al., 2013). Therefore, DLK’s role in axon regeneration is 
evolutionarily conserved among all the model organisms.   
1.3.3 DLK functions as a sensor of axonal damage 
Given the functions mentioned above, DLK has been thought to act as a ‘sensor’ of 
axonal damages and thus should become activated upon axonal injuries. Indeed, there are several 
lines of evidence to support that. First, Wnd is both anterogradely and retrogradely transported in 
axons (Xiong et al., 2010). Moreover, Wnd is required acutely in injured axons to retrogradely 
transport signals to cell bodies that facilitate axon regeneration (Xiong et al., 2010, Shin et al., 
2012a). However, how DLK senses axonal damages is still not clear.  
1.3.4 Regulation of DLK signaling 
DLK is predominantly expressed in neurons in cytosol, plasma membranes and nuclei. 
DLK is actively transported in axons (Xiong et al., 2010, Holland et al., 2016) and its level 
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increases acutely in neurons upon axonal injury (Xiong et al., 2010, Hao et al., 2016) or nerve 
growth factor (NGF) withdrawal from medium in cultured neurons (Huntwork-Rodriguez et al., 
2013). So it is known as a sensor for neuronal damage and NGF withdrawal induced stress. And 
the acute up-regulation of DLK levels involves posttranscriptional mechanisms (Huntwork-
Rodriguez et al., 2013, Xiong et al., 2010). Despite great interest, the mechanisms by which 
DLK is activated and stabilized are still not fully understood. My thesis work has focused on 
seeking evolutionarily conserved upstream components of the DLK signaling pathway. Before 
diving into the details of my studies, I review here the known regulatory mechanisms of DLK.   
1.3.4.1 DLK dimerization and auto-phosphorylation 
DLK is a serine/threonine kinase that belongs to mixed lineage kinase (MLK) subfamily 
of protein kinases (Holzman et al., 1994). It is a large protein (888 amino acids in mice) that 
characterized by a catalytic domain (amino acids 156-404) and two Leucine zipper motifs.  DLK 
forms dimers through the Leucine zippers and the two dimers can phosphorylate each other 
(called auto-phosphorylation). It has been shown that the auto-phosphorylation is required for the 
activation of DLK downstream targets (Nihalani et al., 2000). However it is not clear which sites 
are phosphorylated during the auto-phosphorylation.  
1.3.4.2 regulation of DLK by calcium 
One study in C.elegans has identified novel DLK-1 isoform DLK-1S, which binds to 
DLK-1L and inhibits DLK function (Yan and Jin, 2012). Increased intracellular calcium level 
switches the heteromeric protein complex to homomeric protein complex, and DLK-1 is 
therefore activated. Although the C-terminal calcium binding hexapeptide is conserved in one 
isoform of DLK (MAP3K13), so far there is no evidence suggesting mammalian DLK can be 
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regulated by calcium. Instead, some studies suggest that DLK can be activated through a calcium 
independent mechanism (Valakh et al., 2015). 
1.3.4.3 JNK stabilizes DLK via a feedback mechanism 
JNK is a MAP kinase (MAPK) that functions downstream of DLK in mediating 
retrograde axonal injury signaling (Xiong et al., 2010, Holland et al., 2016). In the cultured 
embryonic DRG neurons, withdrawal of NGF from serum leads to DLK-dependent cell death 
(Watkins et al., 2013). A recent study discovered that upon the NGF withdrawal, DLK level 
increases dramatically within 3 hours in DRGs (Huntwork-Rodriguez et al., 2013). Moreover, 
the stabilization of DLK requires JNK, since block of JNK with inhibitors abolished this effect. 
Further studies suggested that JNK may directly phosphorylate DLK at T43 and S533 outside of 
the kinase domain, and this phosphorylation changes DLK’s sensitivity to degradation via the 
ubiquitin proteasome system (UPS) (Huntwork-Rodriguez et al., 2013). However, JNK 
activation alone does not lead to the activation of DLK.  
1.3.4.4 Palmitoylation of DLK  
A recent study showed that DLK is palmitoylated at a highly conserved site (C127) near 
the kinase domain (Holland et al., 2016). The point mutation DLKC127A fails to associate with 
vesicles and fails to be transported in axons. Since DLK is required for the retrograde transport 
of injury signaling in axons, the palmitoylation of DLK is crucial for its function. However, it is 
not clear that whether the activation of DLK requires palmitoylation..  
1.3.4.5 DLK functions as both a sensor and a mediator of microtubule dynamics 
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Disruption of microtubule by either treating cultured neurons with cytoskeleton 
destabilizing drug in vitro or mutating microtubule stabilizing protein spectraplakin in 
Drosophila in vivo activates DLK (Valakh et al., 2015, Valakh et al., 2013). Interestingly, DLK 
is also required for the increased the microtubule dynamics after axonal injury (Ghosh-Roy et al., 
2012). This section is discussed in detail in Chapter 2.   
1.3.4.6 mTOR and Akt 
Mechanistic target of rapamycin complex 1 (MTORC1) and PI3K/Akt are known for 
their roles in regulating cell growth (Wong et al., 2015). Interestingly, studies suggest that both 
of them can directly phosphorylate DLK and regulate its activity under specific conditions. 
MTORC1 modulates synaptic growth via regulating the DLK pathway — MTORC1 
phosphorylates DLK at its kinase domain (Wong et al., 2015). Akt regulates embryonic stem cell 
proliferation via phosphorylation DLK at its C-terminal (Wu et al., 2015).   
1.4 Axon degeneration 
After acute axonal injury, the distal axonal stump that lost connection undergoes a self-
destruction process called Wallerian degeneration. After a lag phase (the length of the period 
varies in different types of neurons and also in different species), the distal axonal stumps 
undergo a rapid degeneration process characterized by disappearance of cytoskeleton and 
fragmentation of axonal membrane. Then the axonal debris are cleared away by glia and other 
immune cells. This process morphologically resembles the axon degeneration process in many 
neurodegenerative diseases and neuropathies.  
The discovery of the gain-of-function mutation Wallerian degeneration slow (WldS), 
which slows down Wallerian degeneration for weeks in mice suggested that axon degeneration 
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may be a regulated active process, akin to apoptosis. Remarkably, WldS is also able to suppress 
axon degeneration in neurodegenerative diseases and neuropathies models, suggesting that these 
processes share similar molecular mechanisms with Wallerian degeneration. Therefore, 
Wallerian degeneration can be used as a model to study the mechanism of axon degeneration. 
Given WldS is a gain-of-function mutation, there must be other endogenous mechanisms that 
regulate axon degeneration. In the past decade, studies using various axonal injury models in 
multiple organisms have identified several critical regulators of axon degeneration. Here I review 
the most significant discoveries that influenced our understanding of this fundamental process.  
1.4.1 Nmnat 
Since the discovery of WldS, extensive studies have been focused on the molecular 
mechanisms by which it protects axon degeneration. Now it is widely acknowledged that the 
nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1) is the functional component of 
WldS (Conforti et al., 2009). Nmnat is the enzyme for Nicotinamide adenine dinucleotide (NAD) 
biosynthesis, catalyzing nicotinamide mononucleotide (NMN) or nicotinic acid mononucleotide 
(NaMN) with ATP to form NAD or NaAD (Schweiger et al., 2001). There are three isoforms of 
Nmnat proteins in mammals (Nmnat1, Nmnat2 and Nmnat3). While Nmnat1 mainly resides in 
the nuclei and Nmnat3 localizes in mitochondria, Nmnat2 is in the cytosol and actively 
transported in axons (Berger et al., 2005). Nmnat2 is believed to be the ‘survival factor’ for 
axons, since knockout of Nmnat2 led to spontaneous axon degeneration (Gilley and Coleman, 
2010, Gilley et al., 2013). The protective effect of WldS is due to the mislocalization of Nmnat1 
into axons. However, the mechanism by which Nmnat regulates axon degeneration is not clear, 
yet of great interest. While some studies suggested its enzymatic activity for NAD+ synthesis is 
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important (Conforti et al., 2014), other studies proposed that it functions molecular chaperon (Ali 
et al., 2011, Ali et al., 2016).  
1.4.2 Hiw 
Hiw, an E3 ubiquitin ligase that plays a key role in modulating synapse development 
(Collins et al., 2006, DiAntonio et al., 2001), was identified as a promoter of axon degeneration 
via down-regulation of Nmnat protein through ubiquitination in Drosophila (Xiong et al., 2012).  
This mechanism is demonstrated to be conserved in mammals (Babetto et al., 2013). The role of 
Hiw in promoting axon degeneration has also been identified through an elegant unbiased 
genetic screen using Drosophila adult wing injury model (Neukomm et al., 2014), suggesting 
Hiw is one of the key regulators for axon degeneration.  
1.4.3 Sarm1 
An elegant genetic screen in Drosophila has identified dSarm (Drosophila sterile alpha 
and Armodillo motif containing protein) as a core regulator of Wallerian degeneration (Osterloh 
et al., 2012). dSarm is highly conserved between flies and mammals as the mammalian homolog 
Sarm1 is also required for axon degeneration (Osterloh et al., 2012, Gerdts et al., 2013). 
Interestingly, a recent study suggests that Sarm1 promotes axon degeneration by locally breaking 
down NAD+, the metabolite of Nmnat (Gerdts et al., 2015). Moreover, there are other 
compelling data suggest Nmnat2 protects axon degeneration via inhibition of Sarm1 (Gilley et al., 
2015, Gilley et al., 2013) (Sasaki et al., 2016). These studies tie Sarm1 and Nmnat together into 
what appears to be a common pathway for axonal destruction. 
1.5 Overview 
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In this thesis, I will describe my findings about the mechanisms of axon regeneration as 
well as axon degeneration.  
Chapter 2 will be a review about the intrinsic mechanisms of axon regeneration, with 
specific emphasis on the recent significant findings in Drosophila. This chapter also discusses 
the merits of using Drosophila as a model organism to study molecular mechanisms of axonal 
injuries.  
Chapter 3 will mainly focus on identification of a novel regulator of DLK in modulating 
axon regeneration. DLK is known to play a critical role in axon regeneration, however it is not 
clear how it is activated and stabilized after injury. In this chapter, I will demonstrate that cAMP 
and protein kinase A (PKA) are direct upstream activators of DLK upon axonal injury. Moreover, 
PKA also stabilizes DLK via a JNK independent mechanism.  
Chapter 4 will focus on identification of a novel axon degeneration promoter in 
Drosophila. This protein is named Raw in Drosophila and known to play important roles during 
development. I will show that Raw is required for axon degeneration in different types of 
neurons via function upstream of a highly conserved transcription factor Fos.  
Chapter 5 will summarize these findings and discuss relevant studies in the field, as well 
as future research directions.   
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Chapter 2 :  
Intrinsic mechanisms for axon regeneration: insights from injured axons in 
Drosophila 
 
2.1 Abstract 
Axonal damage and loss are common and negative consequences of neuronal injuries, 
and also occur in some neurodegenerative diseases. For neurons to have a chance to repair their 
connections, they need to survive the damage, initiate new axonal growth, and ultimately 
establish new synaptic connections. This review discusses how recent work in Drosophila 
models have informed our understanding of the cellular pathways used by neurons to respond to 
axonal injuries. Similarly to mammalian neurons, Drosophila neurons appear to be more limited 
in their capacity regrow (regenerate) damaged axons in the central nervous system, but can 
undergo axonal regeneration to varying extents in the peripheral nervous system. Conserved 
cellular pathways are activated by axonal injury via mechanisms that are specific to axons but 
not dendrites, and new unanticipated inhibitors of axon regeneration can be identified via genetic 
screening. These findings, made predominantly via genetic and live imaging methods in 
Drosophila, emphasize the utility of this model organism for the identification and study of basic 
cellular mechanisms used for neuronal repair. 
2.2 Introduction 
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As the fundamental conduit for communication with other neurons, a neuron’s axon is 
one of its most vulnerable features. An injury at any position in an axon’s length leads to a 
silencing of its function. How do nervous systems cope with axonal damage? Neurons are 
expected to last for an animal’s lifetime, so re-development and replacement of the damaged 
neuron is not an option in the adult nervous system. Instead, neuronal repair, when it occurs, 
requires that the neuron maintain survival through the damage and then initiate new axonal 
growth (termed ‘axon regeneration’) to re-form its lost connection. A neuron’s ability to do this 
varies widely depending on what type of neuron it is, where the damage occurs, the presence of 
both extrinsic and intrinsic inhibitors of regeneration, and the cell’s ability to organize its 
cytoskeleton to initiate new axonal growth. Towards the most idealistic goal of stimulating repair 
after nervous system damage, there is much interest in understanding what these factors are. 
Over the past decade, studies in invertebrate model organisms such as Drosophila and C. elegans 
have made increasingly important contributions to this goal, with discoveries made through 
genetic screens and live imaging techniques in these model organisms that take advantage of 
their simplified nervous systems and powerful genetic tools. In cases where it has been examined 
thus far, mechanisms identified in the invertebrate models have later been confirmed to be 
important in mammalian neurons. 
In this review, we highlight recent and provocative discoveries made in Drosophila 
around the topic of responses to axonal and dendritic injuries. A number of different injury 
assays have been developed in the adult and larval nervous system and are reviewed in more 
detail in (Brace and DiAntonio, 2016, Fang and Bonini, 2012, Rooney and Freeman, 2014). 
Studies of axon degeneration in Drosophila have made groundbreaking discoveries and are also 
reviewed in more detail in (Rooney and Freeman, 2014).  Here we focus on axon regeneration, 
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and also some of the interesting comparisons that can be made between injuries to axons verses 
injuries to dendrites. 
2.3 Drosophila as a model to study intrinsic mechanisms for repair 
A central feature of the mammalian nervous system is that axon regeneration occurs 
readily in the peripheral nervous system (PNS), yet fails to occur in the central nervous system 
(CNS).  There has been great interest in understanding this dichotomy, since regeneration failure 
in the adult mammalian CNS is a major debilitating aspect of many neuronal injuries. One 
known reason for the dichotomy is the presence of proteins in CNS myelin that inhibit axonal 
growth, termed ‘extrinsic’ inhibitors (reviewed by (Silver et al., 2015)). Another is an ‘intrinsic’ 
incapability of neurons to initiate new axonal growth after damage in the CNS. Several landmark 
studies have shown that the intrinsic incapacity to regenerate can, at least for some neurons, be 
overcome through manipulations to cAMP or mTOR intracellular signaling pathways (Cai et al., 
1999, Park et al., 2008, Qiu et al., 2002, Sun et al., 2011). How this capacity is either locked or 
unlocked, including how these pathways are regulated and utilized for this gating, is a topic of 
great interest in the field. 
The Drosophila nervous system lacks myelin and many of the known extrinsic inhibitors 
of regeneration that are expressed by oligodendrocytes (eg. Nogo, OgMp, and MAG). However, 
despite this absence, the PNS/CNS dichotomy for may potentially also exist in Drosophila: new 
axonal growth can be observed in several different injury methods to motor and sensory neurons 
in the larval and adult PNS (reviewed in (Brace and DiAntonio, 2016)). However, in two injury 
assays described thus far in the larval and adult CNS, limited axonal sprouting was observed 
after injury (Song et al., 2012, Ayaz et al., 2008), and this lack of regeneration can be at least 
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partially bypassed by manipulations to the cAMP or the mTOR pathways (Song et al., 2012, 
Ayaz et al., 2008), echoing observations in mammalian neurons. Injuries in the CNS are 
inherently more likely to disrupt multiple neurons and synapses, and it is difficult to make direct 
comparisons across different injury methods and locations, so further studies are needed. 
However the similarities noted thus far suggest that neurons across the animal kingdom use 
similar intrinsic mechanisms to promote or inhibit their capacity to regenerate. Drosophila is 
therefore a reasonable model system to study these intrinsic mechanisms, and it benefits from the 
vast number of existing genetic tools to manipulate cellular signaling pathways on a single cell 
level in the Drosophila nervous system. 
2.4 Intrinsic mechanisms of axon regeneration: discoveries from Drosophila  
2.4.1 Cellular rearrangements in microtubules and organelles 
An important technique for studying cellular responses to axonal damage is live imaging, 
which allows one to track changes in the structure of damaged neurons over time, and changes in 
the localization and abundance of their organelles and cytoskeletal components. For such studies, 
the dendritic arborization (da) neurons that line the larval body wall have been an excellent 
model, since these cells can be imaged in their entirety (cell bodies, dendrites, and axons) 
through the relatively transparent larval cuticle. Based on dendritic branching complexity, these 
sensory neurons are divided into four classes (Class I: most simple; Class IV: most complex) 
(Grueber et al., 2003). With specific GAL4 lines expressing in each type of these neurons, they 
can be genetically labeled and manipulated with single cell resolution. In these neurons, striking 
responses to axonal injury have been characterized to the microtubule cytoskeleton and to the 
endoplasmic reticulum (ER), some of which may be coupled to the neuron’s ability to initiate 
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axon regeneration (Figure 2.2). Here we briefly review some of these changes that take place in 
neurons as they respond to axonal injury.  
A useful tool to study the organization of microtubules in these neurons is to follow 
growth of individual microtubules via live imaging, using the microtubule plus-end binding 
protein EB1-GFP. In axons the microtubules are uniformly oriented with their growing ends 
(‘plus ends’) pointed away from the cell body, while microtubules in mature dendrites are 
oriented with an opposite polarity (Stone et al., 2008, Hill et al., 2012) (Figure 2.2). Strikingly, 
axonal injury (but not dendritic injury) induces a dramatic and global increase in the number of 
growing microtubules throughout the cell body, dendrites, and proximal axon (Stone et al., 2010) 
(Figure 2.2).  
What is the function of this massive induction in new microtubule growth? It appears 
rapidly, within minutes, in neurons that are able to regenerate their axon (Stone et al., 2010), so it 
may reflect or occur alongside important cellular changes that establish this capacity. This 
capacity in the da sensory neurons is truly remarkable: if the axon is completely removed 
(leaving no axonal stump attached to the cell body) then a dendrite becomes restructured and 
transformed an axon (Stone et al., 2010), demonstrating a strong homeostatic drive to have an 
axon. This transformation entails a re-organization of microtubules within the dendrite to form a 
new process with the plus-end out polarity appropriate and specific to axons (Figure 2.2). 
Manipulations that inhibit microtubule growth, including knock-down of the microtubule 
polymerase msps, prevent the dendrite-to-axon transformation, however knock-down of gamma-
tubulin, which inhibits the formation of new microtubules, does not inhibit the transformation 
(Stone et al., 2010, Chen et al., 2012). So the new microtubules may not be primary effectors of 
axonal regeneration, but may instead reflect broad and global effects of an axonal injury 
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response. In fact, current data favors the idea that the induced microtubule growth is a 
neuroprotective response: once the dynamics is induced, neurites that are damaged during 
subsequent injuries become resistant to the process of Wallerian degeneration (Xiong and Collins, 
2012, Chen et al., 2012). Intriguingly, overexpression of expanded polyglutamine proteins (a 
form of proteotoxic stress) seems to engage the same protective response pathway, which 
involves microtubule nucleation via gamma-tubulin and is controlled by activation of  Jun N-
terminal kinase (JNK) signaling (Chen et al., 2012). After time (72 hours after axonal injury), the 
microtubule dynamics ultimately quiet down, and manipulations that prolong the response can 
actually inhibit axonal regeneration (Stone et al., 2010, Chen et al., 2012). This builds a model 
that major aspects of the axonal injury response, including the global changes in microtubule 
dynamics, may serve as an initial protective response but must ultimately subside before the 
neuron can initiate substantial new growth from its axon. 
In addition to the global changes in microtubule structure induced by axonal injury, 
injury within any neurite (either axon or dendrite) also induces local changes in microtubule 
polarity (Song et al., 2012, Lu et al., 2015). This likely occurs via calcium-stimulated 
depolymerization of microtubules near the injury site, and treatments that block this polarity 
change in cultured neurons (eg., low concentrations of vinblastine applied immediately following 
axonal injury) completely inhibit axon regeneration (Lu et al., 2015). These local changes allow 
for microtubules of opposing polarities to orient at the new ‘tips’ of the injured neurite. This 
creates a scenario for microtubule sliding, driven by the kinesin-1 motor protein, which can link 
to oppositely polarized microtubules and power them further apart (Lu et al., 2015). The 
microtubule sliding ability of kinesin-1 plays an important role in promoting axonal outgrowth 
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during development (del Castillo et al., 2015, Winding et al., 2016), and genetic knock-down of 
kinesin-1 leads to failed axon regeneration in in vitro assays (Lu et al., 2015).  
Another important factor in axon regeneration is the microtubule severing protein Spastin: 
deletion of a single copy of Spastin can dominantly impair regeneration, and over-expression of 
Spastin also impairs regeneration, suggesting that the process is very sensitive to gene dose of 
Spastin (Stone et al., 2012). Manipulations of Spastin have no obvious effects upon the global 
increase in microtubule dynamics induced by axotomy (Stone et al., 2012). Instead, a recent 
study suggests an important role for Spastin in its ability to associate with the ER as well as 
microtubules. Spastin and Atlastin, another protein with similar ER-microtubule association roles, 
mediate an enhanced localization of ER and microtubules into the growing tips of regenerating 
axons ((Rao et al., 2016) and Figure 2.2). Since the calcium-releasing function of ER in the 
growth cone has been shown to play an important role in growth cone guidance and axon 
regeneration (Sun et al., 2014, Takei et al., 1998), the localization of ER to a regenerating axon 
tip could promote regeneration by providing intracellular calcium locally.  
2.4.2 Axonal damage signaling via the DLK kinase 
Work in multiple model organisms from C. elegans and Drosophila, followed by later 
studies in mice has identified the dual leucine zipper kinase (DLK, also known as Wallenda 
(Wnd) in Drosophila) as an essential mediator of a neuron’s ability to initiate new axonal growth 
(reviewed by (Tedeschi and Bradke, 2013)). This kinase is not required for axonal outgrowth 
during development, but its function is essential for neurons to initiate new growth after injury. 
Upon axonal injury, Wnd/DLK mediates the retrograde transport of the ‘injury signals’ in axons. 
The JNK MAP Kinase and transcription factor Fos are required for Wnd/DLK mediated axonal 
regeneration, suggesting a transcriptional response is involved (Xiong et al., 2010). Moreover, 
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studies in C. elegans found that the DLK pathway also regulates microtubule dynamics after 
injury via tubulin posttranscriptional modifications (Ghosh-Roy et al., 2012). This is consistent 
with the findings in Drosophila that JNK mediates the acute response of microtubule dynamics 
after injury (Stone et al., 2010). Therefore, Wnd/DLK appears to function as an upstream 
regulator of multiple cellular responses to axonal damage. Interestingly, Wnd/DLK is actively 
transported (associated with vesicles) in axons and becomes acutely activated upon axonal injury 
(Xiong et al., 2010, Holland et al., 2016). Thus, it may be able to ‘sense’ axonal damage locally 
in axons.   
What determines DLK’s activation after axonal damage? It is interesting that multiple 
studies in Drosophila, C. elegans and mammalian neurons have suggested that Wnd/DLK 
signaling is sensitive to manipulations that alter cytoskeletal structure in neurons, including 
mutations in spectraplakin, TCP1α or TCP1β, and treatment with nocodazole or cytochalasin D 
(Valakh et al., 2013, Valakh et al., 2015, Bounoutas et al., 2011, Kurup et al., 2015, Voelzmann 
et al., 2016, Massaro et al., 2009), hence axonal damage per se is not the only way to activate 
DLK. These observations suggest a central role for Wnd/DLK as a both a sensor and regulator of 
cytoskeletal structure in neurons. However, it is not yet clear how this kinase actually senses 
cytoskeletal changes on a mechanistic level. This is an interesting area of future work, 
particularly since several recent studies in mammalian neurons have implicated DLK in neuronal 
degeneration and death, including in models of glaucoma and excitoxicity (Watkins et al., 2013, 
Welsbie et al., 2013, Ghosh et al., 2011, Pozniak et al., 2013). Therefore, while DLK activation 
is important for axonal regeneration, it may be of greater interest to inhibit (rather than promote) 
in order to minimize pathology in neurodegenerative diseases and injury.  
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Other clues to DLK’s activation mechanism may come from the biochemical 
identification of the upstream activators that can stimulate the activation loop of the Wnd/DLK 
kinase. Recent work has discovered such an activity for the cAMP effector kinase protein kinase 
A (PKA), which can induce Wnd’s activation and function, and is required for its activation in 
injured axons (Hao et al., 2016). Genetic interaction studies have also led to the suggestion that 
Wnd may also be regulated by TORC1 (Wong et al., 2015). It is striking that, as discussed 
previously, both cAMP and mTOR signaling are known for abilities to unlock axonal 
regeneration potential. Importantly, DLK is also similarly regulated by cAMP and PKA in 
mammalian as well as Drosophila neurons (Hao et al., 2016). This suggests an interesting 
possibility that DLK activation could a key feature for the ‘unlocking’ mechanism, and a 
potentially universal mechanism for stimulating axonal regeneration.   
2.4.3 Regulation of RNA-processing pathways 
Use of Drosophila injury models for forward genetic screens allows for the discovery of 
new  unanticipated regulators of axon regeneration. A recent example is the discovery of an 
RNA processing enzyme Rtca (RNA 3’-terminal phosphate cyclase), as a potent inhibitor of 
axon regeneration: mutations in Rtca allow for sensory neuron axons to grow in the CNS, and 
overexpression of Rtca causes an inhibition to axon regeneration in the PNS (Song et al., 2015). 
Following on this discovery, Song et al then demonstrated that the mammalian ortholog of Rtca 
functions similarly as an inhibitor of axonal regeneration in adult DRG neurons in culture and in 
the adult optic nerve in vivo. Known substrates of Rtca include mediators in the tRNA splicing 
pathway, and the ER-stress response factor X-box protein 1 (Xbp-1), whose non-canonical intron 
shares features and regulation with the tRNA splicing pathway (Yoshida et al., 2001). Song et al 
suggested that Xbp-1 may be the target of Rtca during axonal regeneration since the enhanced 
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regeneration observed in Rtca mutants was largely abolished in Xbp-1, Rtca double mutant flies. 
Such a role for Xbp-1 in axon regeneration would be consistent with other recent studies that 
have noted roles for ER stress pathways in regeneration (Onate et al., 2016, Ying et al., 2015). 
However, the genetic data alone cannot exclude other potential (and yet unknown) targets of 
Rtca regulation. Interestingly, a recent study in C. elegans identified the tRNA ligase Rtcb as an 
inhibitor of axon regeneration, but ruled out both Xbp-1 and tRNAs as functional targets for Rtcb 
in this function (Kosmaczewski et al., 2015). These findings suggest that much remains to be 
learned about the ‘RNA dimension’ of responses to axonal injury: we may have glimpsed only 
the tip of an iceberg that remains to be charted. 
2.5 How are responses to dendritic injury different from axonal injury? 
Many neuronal injuries entail loss of dendrites as well as axons. The highly characterized 
anatomy of Drosophila da neurons has turned into an exciting model system for comparing and 
contrasting the differences between dendritic and axonal injury. After laser-induced removal, da 
neurons show a robust ability to regrow their dendritic arbors (Thompson-Peer et al., 2016, Stone 
et al., 2014, Song et al., 2012), even when carried out in adult flies (Stone et al., 2014). While for 
some classes the regenerated dendrites cannot cover the entire lost territory and the architecture 
is not completely restored, the regenerated dendrites show a remarkable ability to re-grow the 
stereotyped pattern of primary branches according to their class type (Stone et al., 2014, 
Thompson-Peer et al., 2016). Strikingly, nearly all of the aspects of axon regeneration described 
above are not required for dendrite regeneration: dendrite regeneration does not require DLK or 
Spastin (Stone et al., 2012, Stone et al., 2014), and occurs independently of global microtubule 
rearrangements and ER relocalization (Stone et al., 2010, Rao et al., 2016). Dendrite 
regeneration and axon regeneration are therefore fundamentally different processes. This does 
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not mean that some basic cellular components may mediate both. The AKT-PTEN signaling, 
classically associated with cellular growth, is required both axon and dendrite regeneration (Song 
et al., 2012). Since mixed polarity microtubules form at the tips of injured dendrites (Song et al., 
2012), kinesin-driven microtubule sliding is another candidate mediator of renewed dendrite 
growth, particularly since microtubules also have mixed (opposing) polarity in dendrites during 
their original developmental outgrowth (Hill et al., 2012). However these ideas remain to be 
further tested and require further basic understanding of the mechanisms that promote dendrite 
growth, and how these are distinct from axonal growth. 
Comparison of dendritic injury with axonal injury has also revealed some differences in 
degeneration, defined here as the process by which the injured piece that is separated from the 
cell body becomes dismantled.  This process requires a ‘self-destruction’ pathway which 
functions cell autonomously in the injured neurite, and studies of axon degeneration in 
Drosophila have identified many key players in this process (reviewed by (Neukomm and 
Freeman, 2014)). We know that at least some of the genetic manipulations that inhibit axon 
degeneration also inhibit dendrite degeneration (Tao and Rolls, 2011). However, studies of 
dendrite degeneration in Drosophila suggest the existence of aspects that are distinct from axons, 
such as specific requirement for the microtubule-severing protein fidgetin in dendrite but not 
axon degeneration (Tao et al., 2016). Live imaging data suggest that Fidgetin promotes an 
increase in microtubule number, presumably via its severing activity, followed by microtubule 
disassembly in distal dendrites. This response contrasts with axonal injury as described above, 
which promotes a global increase throughout the cell body (including all dendrites and the 
proximal stump), but not in distal axon stump (Stone et al., 2010). These differences further 
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emphasize that axons and dendrites respond distinctly to injuries and distinct mechanisms are 
involved.  
2.6 Can functional reconnection occur after axon injury in Drosophila? 
Initiation of new axonal growth is only the first step towards repairing lost connections. 
True repair requires that regenerating axons find their targets and form functional synapses. In 
general this process of ‘synapse regeneration’ is poorly studied in the field. To date, it has not 
been noted in any of the Drosophila models of injury, however the Drosophila system may 
present future opportunities to study this process. Earlier studies in other invertebrate, including 
cockroaches, leech, Aplysia, snails, crayfishes and crickets, suggest functional regeneration can 
indeed happen. By following the process in a system that is tractable to cell-specific genetic 
manipulations, live imaging and behavioral screening, one could determine whether synapse 
regeneration follows the same pathways as synapse development, whether axon regeneration 
pathways need to be turned off to initiate synapse formation, and what role remaining synapses 
within the injured circuit play in the process. We predict that exciting work lies ahead in this 
powerful model organism. 
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2.7 Figures 
Figure 2.1 
 
 
 
Figure 2.1Axons regenerate to varying extents in different Drosophila axon injury models 
New axonal growth after injury, cartooned in pink, occurs to varying degrees after 
injuries in the adult and larval PNS. Some of the sensory neurons that line the larval body wall 
initiate remarkable regeneration along the original path of the lost axon (Song et al., 2012).  
Other injury models in the adult wing and larval peripheral nerves note extensive new axonal 
sprouting (Xiong et al., 2010, Soares et al., 2014). This undirected growth (‘sprouting’) may 
reflect an absence of salient cues to guide directed growth for the regenerating axon. In some 
cases, sensory neurons in the adult wing can initiate extensive directed growth, however this 
occurs along a new path that is distinct (‘misrouted’) from the original path (Soares et al., 2014). 
This may be a side effect of massive tissue damage and scar formation at the injury site that 
prevents the axon from finding its correct path. 
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In contrast to the PNS injuries, the two studies thus far that have injured axons in the 
CNS have noted very poor growth responses (Song et al., 2012, Ayaz et al., 2008). The contrast 
is particularly interesting for the Class IV da sensory neuron axons, since the axons grow 
robustly after injury in a PNS location but very poorly after injury in a CNS location (Song et al., 
2012, Song et al., 2015).  
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Figure 2.2 
 
 
Figure 2.2 Injury triggered microtubule dynamics in neurons 
Microtubules are organized in axons and dendrites with distinct orientations of their 
growing (plus) ends: in axons microtubules orient with plus ends facing away from the cell body 
(plus-end-out), colored green, while in dendrites microtubules orient with minus-ends-out, 
colored red. Axonal injury, but not dendritic injury, triggers a global increase in the number of 
growing microtubules. In contrast, increased microtubule is observed in distal dendrite stump, 
but not distal axon stump. Mixed-polarity microtubules are observed in both proximal axon 
stump and dendrite stump. ER and microtubules are accumulated in growing axon tips, but not in 
growing dendrite tips, 96 hours after axotomy (for class I da neuron). In the case of completely 
axonal removal, one dendrite can switch microtubule polarity and become a growing axon.  
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Chapter 3 :  
An evolutionarily conserved mechanism for cAMP elicited axonal 
regeneration involves direct activation of the dual leucine zipper kinase DLK 
 
3.1 Abstract 
A broadly known method to stimulate the growth potential of axons is to elevate 
intracellular levels of cAMP, however the cellular pathway(s) that mediate this are not known. 
Here we identify the Dual Leucine-zipper Kinase (DLK, Wnd in Drosophila) as a critical target 
and effector of cAMP in injured axons. DLK/Wnd is thought to function as an injury ‘sensor’, as 
it becomes activated after axonal damage. Our findings in both Drosophila and mammalian 
neurons indicate that the cAMP effector kinase PKA is a conserved and direct upstream activator 
of Wnd/DLK. PKA is required for the induction of Wnd signaling in injured axons, and DLK is 
essential for the regenerative effects of cAMP in mammalian DRG neurons. These findings link 
two important mediators of responses to axonal injury, DLK/Wnd with cAMP/PKA, into a 
unified and evolutionarily conserved molecular pathway for stimulating the regenerative 
potential of injured axons.  
3.2 Introduction 
Repair of lost axonal connections generally fails to occur after neuronal injury in the 
adult mammalian central nervous system (CNS). This failure is not only a reflection of the 
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growth inhibitory nature of CNS tissue (Fawcett et al., 2012, Filbin, 2003, Silver et al., 2015), 
but also due to the lack of intrinsic capacity for neurons in the adult CNS to grow axons (Liu et 
al., 2011, Sun and He, 2010). However, landmark studies by Richardson and Issa have suggested 
that neurons indeed possess an innate ability to regenerate their axons in the adult mammalian 
CNS, and that this ability can be unlocked by a ‘conditioning lesion’ (Richardson and Issa, 1984).  
In adult DRG neurons, an injury to peripherally projecting axons, i.e. a compression injury to the 
sciatic nerve, unleashes growth programs within the DRG and allows for regeneration of its 
centrally projecting axons in the spinal cord (Neumann and Woolf, 1999, Richardson and Issa, 
1984). This growth can be induced by a PNS lesion even after the CNS lesion has occurred 
(Ylera et al., 2009), hence it is of great interest from a therapeutic perspective to understand the 
molecular mechanisms that allow for the unlocking of such regenerative potential. 
Previous studies have discovered that several signal transduction pathways are activated 
in DRG neurons upon a conditioning injury, including JAK-STAT3 (Qiu et al., 2005), ATF3 
(Fagoe et al., 2015, Hollis and Zou, 2012), Smad1 (Zou et al., 2009), Activin (Omura et al., 
2015), HIF-1alpha (Cho et al., 2015) and cAMP (Qiu et al., 2002, Neumann et al., 2002, Cai et 
al., 1999). Impressively, ectopic elevation of cAMP alone is sufficient to strongly enhance 
regeneration (Xiao et al., 2015b, Qiu et al., 2002, Neumann et al., 2002).  Since this second 
messenger is commonly modulated by growth signals and neuronal activity, cAMP modulation 
has been suggested as a potential therapeutic inroad to stimulate the regenerative potential of 
neurons (Xiao et al., 2015b).  However, the downstream pathways that are engaged by this 
broadly utilized second messenger to actually promote axonal regeneration are not known.  
Much attention has focused upon the cAMP-responsive element binding protein (CREB), since 
constitutive activation of CREB is sufficient to stimulate axonal regeneration in the presence of 
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CNS myelin in vivo (Gao et al., 2004). However, more recent studies indicate that endogenous 
CREB is not required for cAMP elicited axonal regeneration in vitro (Ma et al., 2014). Hence it 
remains elusive how cAMP elevation activates axonal regrowth programs in neurons.  
A recent study has identified an essential role for the dual zipper-bearing kinase DLK in 
the pro-regenerative effect of a conditioning lesion in adult DRG neurons (Shin et al., 2012a). 
Similarly, the Drosophila homologue Wallenda (Wnd), mediates protective effects of a 
conditioning lesion in Drosophila motoneurons (Brace and DiAntonio, 2016, Xiong and Collins, 
2012). This conserved axonal mitogen activated kinase kinase kinase (MAPKKK) is thought to 
function as a sensor of axonal damage, and therefore should become activated upon conditioning 
injury. In support of this, Wnd/DLK is transported in axons (Xiong et al., 2010) and is required 
acutely in injured axons for the generation of signals that are retrogradely transported to the cell 
body (Xiong et al., 2010, Shin et al., 2012a). DLK/Wnd is required for axonal regeneration in 
many types of neurons, including motoneurons in mammals, flies and worms, and CNS neurons 
where regeneration is ectopically induced by PTEN mutations (Yan et al., 2009, Hammarlund et 
al., 2009, Xiong et al., 2010, Shin et al., 2012a, Watkins et al., 2013). Conversely, in mammalian 
CNS neurons that do not regenerate (eg. retinal ganglion cells, RGCs), DLK activation after 
injury mediates cell death (Welsbie et al., 2013, Watkins et al., 2013).  
Collectively, these findings support the model that a conserved function of the Wnd/DLK 
kinase is to ‘sense’ axonal damage. Through a yet unknown mechanism, axonal damage leads to 
activation of Wnd/DLK’s kinase function. Once activated, downstream signaling mediates both 
beneficial and deleterious outcomes in neurons, depending upon the context. The high stakes 
outcomes of regeneration or death, combined with additional findings that DLK mediates cell 
death in models for nerve growth factor withdrawal (Huntwork-Rodriguez et al., 2013, Ghosh et 
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al., 2011), glaucoma (Welsbie et al., 2013), MPTP toxicity (Mathiasen et al., 2004)  and 
excitotoxicity (Pozniak et al., 2013), have inspired much interest in understanding the unknown 
pathways that lead to the activation of DLK/Wnd in injured axons. 
Here we identify a direct upstream activator of DLK/Wnd in injured axons, in the form of 
the cAMP effector kinase PKA.  We find that PKA phosphorylates evolutionarily conserved 
serines within the activation loop of DLK, which is sufficient to activate DLK independently of 
its downstream signaling mechanisms.  In addition, our functional studies in both Drosophila 
motoneurons and adult mammalian DRG neurons indicate that the ability of cAMP and PKA to 
promote axonal regeneration depends entirely upon the ability of PKA to activate the DLK/Wnd 
kinase.  These findings present a unified and evolutionarily conserved molecular pathway, from 
cAMP to PKA to DLK, which plays a central role in stimulating the ability of injured axons to 
regenerate.  
3.3 Results 
3.3.1 PKA regulates axonal regeneration via Wnd. 
Previous studies in mammalian and C. elegans neurons suggest that cAMP signaling 
stimulates regenerative axonal growth (Qiu et al., 2002, Neumann et al., 2002, Cai et al., 1999, 
Ghosh-Roy et al., 2010).  To study this axon regeneration pathway in Drosophila, we used 
previously developed axon injury assay in third instar larvae (Xiong et al., 2010), and found that 
knockdown of phosphodiesterase dunce (dnc) or activation of PKA by overexpression of the 
catalytic subunit (PKA
CA
) (Li et al., 1995) led to an enhanced growth response of Drosophila 
motoneuron axons after nerve crush injury (Figure 3.1A).  The new axonal growth from the 
injured proximal stump generally assumes a highly branched shape, characterized by a network 
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of small branches and a general thickening of the axon diameter.  To assess the injury response, 
we quantified the total membrane volume within 100 µm of the axonal tip (indicated by the dash 
line in Figure 3.1A).  In control animals, this total volume increases 3 fold, from 68.5 µm
3
 to 200 
µm
3
 15 hours after injury.  PKA activation led to a 1.5 fold increase in this volume compared to 
control (WT) axons (Figure 3.1B).  The enhanced sprouting response stimulated by PKA was 
lost when DLK/Wnd function was inhibited by co-expression of RNAi targeting Wnd (but not a 
control RNAi) (Figure 3.1A and B).  These observations are consistent with the previous finding 
in C.elegans that DLK is required for the regeneration that is induced by cAMP signaling 
(Ghosh-Roy et al., 2010).  In addition, PKA alone is required for Drosophila motoneurons to 
initiate regenerative sprouting, as RNAi-mediated knockdown of the PKA catalytic subunit 
inhibited the sprouting response by 50% compared to control axons (Figure 3.1A and B).  cAMP 
and PKA therefore play an influential role in the regenerative capacity of Drosophila 
motoneuron axons.  
3.3.2 PKA modulates the levels of Wnd and downstream signaling in Drosophila 
motoneurons.  
While the above and previously described genetic interactions (Ghosh-Roy et al., 2010) 
suggest a relationship, whether Wnd/DLK functions downstream of PKA or in a parallel 
pathway cannot be discerned from genetic epistasis alone.  To probe the relationship between 
PKA and Wnd, we first utilized previously established tools in Drosophila for monitoring the 
activation of Wnd and downstream nuclear signaling.  Wnd signaling induces expression of the 
c-Jun N-terminal Kinase (JNK) phosphatase puckered (puc), which can be measured as lacZ 
expression using fly lines that contain the puc-lacZ enhancer trap reporter (Xiong et al., 2010).  
Puc-lacZ is expressed at low levels in uninjured motoneurons, however it is induced by axonal 
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injury in a manner that requires both Wnd and JNK kinase function (Xiong et al., 2010).  We 
found expression of either dnc-RNAi or PKA
CA
 induced the expression of puc-lacZ in 
motoneurons (Figure 2A).  This induction is Wnd dependent, as RNAi knockdown of Wnd (but 
not a control RNAi) rescued the puc-lacZ elevation (Figure 3.2A).  
Previous studies in multiple organisms suggest that Wnd/DLK is highly regulated at the 
level of protein turnover and increased levels of DLK correlate with the activation of 
downstream signaling (Xiong et al., 2010, Huntwork-Rodriguez et al., 2013, Welsbie et al., 2013, 
Collins et al., 2006, Nakata et al., 2005, Nihalani et al., 2000, Hammarlund et al., 2009).   We 
therefore tested whether PKA activation altered Wnd levels.  The total levels of endogenous 
Wnd within 2nd instar larval brains were significantly elevated (by 75%) when PKA
CA
 was 
expressed in neurons (Figure 3.2B).  
To test whether the change of Wnd level is due to a posttranscriptional mechanism, we 
used the Gal4/UAS system to ectopically express a GFP tagged Wnd transgene in Drosophila 
motoneurons.  Since overexpression of WT Wnd can cause lethality, we expressed an inactive 
(kinase dead) version (GFP-Wnd
KD
) that contains a point mutation in the kinase domain (Collins 
et al., 2006).  We found that expression of PKA
CA
 induced a 12-fold increase in the levels of 
GFP-Wnd
KD
 in motoneuron axons (Figure 3.2C).  In contrast, GFP-Wnd
KD
 was not significantly 
altered in cell bodies (Figure 3.2C).  
The increase in axonal GFP-Wnd
KD
 when PKA is induced has remarkable similarity to 
what occurs in axons after injury (Xiong et al., 2010, Huntwork-Rodriguez et al., 2013).  We 
therefore tested whether PKA is required for the induction of Wnd in proximal axons after nerve 
crush injury.  In control (WT) motoneurons, a significant increase in the mean intensity of the 
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GFP-Wnd
KD
 was observed 7 hours after injury (Figure 3.2D).  This increase is abolished by co-
expression of RNAi targeting PKA-C1, but not a control RNAi (Figure 3.2D).  These 
observations suggest that PKA is required for the activation of Wnd signaling and the induction 
of Wnd protein levels downstream of axonal injury.  
 3.3.3 PKA activates DLK through phosphorylation of its activation loop. 
To test whether the regulation of DLK by PKA is conserved in mammalian neurons, we 
examined endogenous DLK protein in cultured embryonic rat cortical neurons.  Treatment with 
forskolin, which activates PKA via elevation of cAMP, led to a 2-fold increase in the level of 
endogenous DLK protein (Figure 3.3A). This effect of cAMP elevation requires PKA, since the 
increase in DLK levels was abolished by co-treatment with the PKA inhibitor H-89 (Figure 
3.3A).  In contrast, treatment with H-89 alone led to a significant reduction in the DLK levels 
(Figure 3.3B).  Similar results were observed in HEK293 cells co-transfected with Flag-tagged 
DLK and either a control empty plasmid or PKA
CA
.  PKA
CA
 induces an approximately two-fold 
increase in DLK protein levels (Figure 3.3E and 3.4B). PKA
CA
 also stimulates a phosphatase-
sensitive increase in DLK molecular weight, which is most visible when equal amounts of DLK 
protein are compared (Figure 3.3F).  
Although the mechanism of DLK activation is unknown, phosphorylation of the 
activation loop is important for activation of other kinases in the mixed lineage kinase family 
that DLK belongs to (Durkin et al., 2004, Leung and Lassam, 2001). Notably, the activation loop 
contains a conserved consensus sequence for PKA (Figure 3.3C), and a recent study has 
demonstrated that the predicted phosphorylation site S302 is required for DLK to activate 
downstream kinases (Huntwork-Rodriguez et al., 2013).  
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To test whether PKA stimulates phosphorylation of DLK’s activation loop (S302), we 
have generated phospho-specific antibodies against a phosphorylated peptide corresponding to 
activation loop of mouse DLK (KELSDKpSTKMpSFAGTV).  The phospho-DLK antibodies 
detected a strong band in HEK293 cells that overexpress WT mouse DLK, but show no 
reactivity for mutant DLK
S302A
 (Figure 3.3D).  Remarkably, expression of PKA
CA
 in HEK293 
cells induces a dramatic increase of phospho-S302 DLK (Figure 3.3E), even when normalized to 
the levels of total DLK (Figure 3.4B). Similar results were observed when cells were treated with 
forskolin for 3 hours (Figure 3.4A).  
Since the activation loop contains a conserved consensus sequence for PKA substrates, it 
should be capable of phosphorylating this site in DLK directly. Indeed, we found that purified 
PKA can strongly stimulate pS302 reactivity upon purified Flag-DLK in vitro (Figure 3.6). 
A recent study in Drosophila has suggested that TORC1 may activate and phosphorylate 
Wnd (Wong et al., 2015), so we considered whether TORC1 plays a role in the activation of 
DLK by PKA. We used both torin1 and rapamycin to inhibit TORC1 in the presence or absence 
of PKA in HEK293 cells. However, in both cases we observed no effect upon DLK and pDLK 
levels (Figure 3.7).  PKA therefore stimulates phosphorylation of DLK’s activation loop 
independently of TORC1 function.  
To confirm that S302 is a critical site for Wnd/DLK function in axonal regeneration, we 
conducted a rescue experiment in Drosophila motoneurons based on the requirement of Wnd for 
axonal sprouting after injury.  We generated UAS-Wnd
S301A,S305A 
 transgenic flies expressing 
Wnd with mutations in two serines  analogous to S298 and S302 in the activation loop of DLK.  
As shown in Figure 3G, all axons in wnd mutants fail to initiate a sprouting response, which can 
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be rescued by co-expression of WT Wnd , but not Wnd
S301A,S305A
.  In addition, overexpression of 
Wnd
S301A,S305A
 does not  give rise to any of the previous described gain-of-function phenotypes 
similar to wild type Wnd, suggesting that S302 is indeed required for DLK function.  
3.3.4 PKA promotes DLK stability independently of downstream signaling. 
A previous study has described a positive feedback loop for DLK stabilization that 
involves the action of DLK’s downstream effector JNK (Huntwork-Rodriguez et al., 2013). JNK 
activation stimulates phosphorylation of DLK at sites outside of its activation loop (T43 and 
S533) and changes DLK’s sensitivity to degradation via the ubiquitin proteasome system (UPS) 
(Huntwork-Rodriguez et al., 2013). This increase in protein stability leads to an increase in total 
levels of DLK. Since PKA stimulates an increase in ectopically expressed DLK, it most likely 
increases protein stability. We therefore tested whether this increased stability involves the 
previously described JNK-dependent feedback mechanism. If this is the case, the effects of PKA 
and forskolin should depend on the function of JNK. As shown in Figure 4A and B, treatment 
with JNK inhibitor VIII led to a 30% decrease in total DLK level, as expected for JNK’s 
previously demonstrated role in promoting DLK stability. However, even in the presence of JNK 
inhibitor, treatment with forskolin (Fig 3.4A) or transfection with PKA
CA
 (Figure 3.4B) increases 
DLK level by 50%. Moreover, treatment with JNK inhibitor had very little effect upon the 
fraction of total DLK that is phosphorylated at S302 (Figure 3.4A and B). These results suggest 
that PKA stimulates DLK phosphorylation and stabilization independently of downstream JNK 
activation. 
Previous biochemical studies suggest that DLK’s activation mechanism is associated with 
dimerization and autophosphorylation (Nihalani et al., 2000, Mata et al., 1996, Merritt et al., 
1999).  We therefore further considered whether PKA could function either upstream or 
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downstream of DLK’s own ability to function as a kinase.  To test this, we utilized a kinase-dead 
version of DLK, DLK
K185A
 , which is unable to activate downstream signaling or undergo 
autophosphorylation (Nihalani et al., 2000, Mata et al., 1996, Merritt et al., 1999).  Consistent 
with the previously described feedback mechanism (Huntwork-Rodriguez et al., 2013), the 
DLK
K185A
 mutant protein was less stable, and addition of JNK inhibitor had no further effect 
upon the levels of kinase dead DLK protein (Figure 3.4C).  However, PKA
CA
 stimulated a strong 
increase of DLK
K185A
  levels and phosphorylation at S302 for DLK
K185A
.  The ability of PKA to 
increase DLK protein stability and activation loop phosphorylation independently of DLK’s own 
signaling abilities places PKA firmly upstream of DLK, as an upstream regulator/activator. 
Since PKA promotes DLK stability and directly phosphorylates S302, we wondered 
whether PKA stabilizes DLK by phosphorylation of S302.  Previous work has shown that a 
decreased stability for DLK
S302A
 mutant protein is linked to the fact that it is inactive for kinase 
activity, and is therefore unable to activate the downstream stabilization mechanism via JNK 
(Huntwork-Rodriguez et al., 2013 and Figure 3.4D). Consistent with this, the reduced levels of 
DLK
S302A
 protein are not further reduced in the presence of JNK inhibitors (Figure 3.4D).  
However surprisingly, co-transfection with PKA
CA
 still caused an increase of the levels of 
DLK
S302A
 protein (Figure 3.4D). We interpret that PKA regulates DLK via an additional 
mechanism, in conjunction with phosphorylation of the critical activation loop S302. This 
additional mechanism may involve other sites of phosphorylation, or other modes of regulation 
(discussed further below). 
3.3.5 PKA stimulates axonal regeneration via DLK in adult DRG neurons. 
Our finding that PKA activates DLK, taken together with previous findings that DLK 
promotes axonal regeneration in different neuronal cell types (Shin et al., 2012a, Xiong et al., 
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2010, Hammarlund et al., 2009, Yan et al., 2009), led to the hypothesis that DLK is an important 
downstream mediator of cAMP-stimulated axon regeneration.  To test this hypothesis, we 
employed a recently described replating assay for DRG neurons cultured from adult mice, which 
allows for a controlled and quantitative measure of the induction of axonal regeneration by in 
vitro manipulations such as forskolin treatment (Frey et al., 2015, Valakh et al., 2015).  In this 
assay (depicted in Figure 5A), DRG neurons removed from adult mice were first cultured for 4-5 
days, which allowed for the regenerative response activated by the dissection to subside.  
Neurons were then treated with forskolin for 24 hours, and then replated onto a fresh dish. The 
replating process removes all existing neurites so that the neurites observed within the second 
culture period can be identified as new growth. As shown in Figure 5B and E, treatment with 
forskolin stimulates the regenerative response (Frey et al., 2015).  In addition, co-treatment with 
H-89 abolished the effect of forskolin on neurite outgrowth (Figure 3.5B-D), suggesting that 
PKA is required.   
To determine whether forskolin-induced neurite outgrowth requires DLK, we performed 
the same experiment in neurons from DLK conditional knockout (KO) mice and littermate 
controls.  The effects of forskolin on neurite outgrowth were abolished in DLK conditional 
knockout DRG neurons (Figure 3.5E-G).  These findings suggest that DLK and its downstream 
signaling pathway(s) are important mediators of the pro-regenerative effects of cAMP elevation 
in neurons.  
3.4 Discussion 
The Wnd/DLK kinase is likely to function as a sensor of axonal damage.  Depending 
upon the context, its activation can lead to either axonal regeneration or cell death and 
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degeneration (Tedeschi and Bradke, 2013).  The factors that determine beneficial versus 
detrimental outcomes, along with the general cellular mechanisms that lead to the activation of 
DLK, are poorly understood.  In this study, we found that an immediate upstream activator of 
DLK is the cAMP regulated kinase PKA.  Elevation of cAMP signaling, which is activated by 
pro-regenerative manipulations such as a conditioning lesion, is the most widely known pathway 
for promoting axonal regeneration (Hannila and Filbin, 2008).  We found that an essential 
component of this regenerative pathway is the activation of Wnd/DLK by PKA.  These findings 
delineate an evolutionarily conserved mechanism for the activation of the Wnd/DLK kinase. 
Taken together with previous findings that Wnd/DLK is an essential regulator of responses 
induced by a conditioning injury (Shin et al, 2012; Xiong and Collins 2012), the activation of 
Wnd/DLK by PKA in injured axons presents a unified molecular pathway for activating a 
regenerative response to axonal damage. 
In contrast to a merging of cAMP and DLK pathways, some other studies have suggested 
that these pathways may act separately (Li et al., 2015, Chung et al., 2016).  A recent study has 
noted that in certain sensory neuron types in C. elegans, PKA gain-of-function mutations can 
induce axonal outgrowth even in dlk mutants (Chung et al., 2016).  Hence, multiple pathways for 
axonal regeneration may be inducible by PKA. However DLK is strongly required for cAMP 
stimulated regeneration in other neuron types in C. elegans (Ghosh-Roy et al., 2010), and, 
importantly, in axonal regeneration induced by a conditioning lesion in the mammalian PNS 
(Shin et al., 2012a). Our findings now indicate that DLK is an important molecular target and 
effector of cAMP-induced regeneration in mammalian neurons. 
Previous biochemical studies indicate that DLK activation involves dimerization via its 
leucine zipper domains and autophosphorylation, at locations that are yet undefined (Nihalani et 
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al., 2000, Mata et al., 1996).  Because ectopic elevation of DLK/Wnd protein is sufficient to 
activate its downstream signaling (Mata et al., 1996, Nihalani et al., 2000, Huntwork-Rodriguez 
et al., 2013), and DLK is known to be highly regulated at the level of protein turnover (Collins et 
al., 2006, Xiong et al., 2010, Huntwork-Rodriguez et al., 2013, Nakata et al., 2005, Hammarlund 
et al., 2009), a plausible mechanism for its regulation is to hold its levels and/or its ability to 
dimerize in check (Mata et al., 1996, Nihalani et al., 2000). The existence of a direct upstream 
activator of the kinase was not previously implied, and has thus far been unknown. Here we 
found that PKA stimulates the phosphorylation of the activation loop of DLK independently of 
DLK’s kinase activity, and also independently of downstream JNK signaling.  This defines PKA 
as an upstream activator of DLK.   
A previous study in C. elegans has described a mechanism through which transient 
elevation of intracellular Ca
2+
 upon axonal injury leads to the activation of DLK-1(Yan and Jin, 
2012, Cho et al., 2013, Ghosh-Roy et al., 2010, Spira et al., 2001).  In addition, earlier studies 
have implicated calmodulin-regulated calcineurin in the regulation of mammalian DLK (Mata et 
al., 1996).  However, the hexapeptide that mediates activation by Ca
2+
 in C. elegans is not 
present in mammalian or Drosophila DLK/Wnd, and mammalian DLK can be activated 
independently of Ca
2+
 elevation by cytoskeletal destabilizing agents (Valakh et al., 2015).  In 
contrast, the consensus PKA phosphorylation site in the activation loop of Wnd/DLK is 
conserved in all phyla (Figure 3.3C), suggesting this pathway as a central (although not 
necessarily exclusive) mechanism for regulating DLK.  
We note that in conjunction with phosphorylation of DLK’s essential activation loop, 
PKA enhances DLK’s stability via an additional mechanism  (Figure 4E), since the mutated 
protein DLK
S302A
 can still be stabilized upon PKA activation. This mechanism may involve 
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additional phosphorylation sites on DLK, and indeed, multiple PKA consensus sequences are 
observed in Wnd/DLK’s sequence (Figure 3.8). However, it is also possible that PKA regulates 
DLK’s stability via other mechanisms, such as previously described ubiquitination (Nakata et al., 
2005, Collins et al., 2006), palmitoylation modification (Holland et al., 2016), changes in DLK’s 
interacting proteins or subcellular localization. Such aspects of regulation could involve 
additional molecular targets of PKA, which would provide some potential for context specificity 
in DLK’s regulation. While PKA has many cellular targets, its specificity can be highly regulated 
at a subcellular level by interactions with AKAP scaffolding proteins and local changes in cAMP 
(Tasken and Aandahl, 2004, Wong and Scott, 2004).  It will be interesting to identify the 
additional players in cAMP and PKA regulation of DLK through future work. 
It is remarkable that PKA stimulates a specific increase in Wnd levels in axons but not 
cell bodies (Figure 3.2C), and inhibition of PKA strongly inhibits the induction of Wnd protein 
after axonal injury (Figure 3.2D).  Does PKA act locally in axons to stimulate DLK? Other 
studies have suggested that Wnd/DLK can regulate retrograde signaling pathways that originate 
in axons (Xiong et al., 2010, Ghosh et al., 2011, Shin et al., 2012a, Huntwork-Rodriguez et al., 
2013, Watkins et al., 2013, Yan et al., 2009, Holland et al., 2016). Intriguingly, the Hiw/Rpm-
1/Phr1 ubiquitin ligase, which is previously known for its role in regulating Wnd/DLK’s levels 
in axons (Collins et al., 2006, Nakata et al., 2005, Lewcock et al., 2007, Babetto et al., 2013), 
contains a RCC1-like domain that biochemically inhibits adenylate cyclase, and therefore may 
negatively regulate cAMP signaling (Pierre et al., 2004). Hiw/Rpm-1/Phr1 is previously known 
for its role in regulating synaptic arborization and growth via its regulation of Wnd/DLK (Nakata 
et al., 2005, Collins et al., 2006, Wang et al., 2013, Wan et al., 2000, Shin and DiAntonio, 2011). 
The addition of cAMP and PKA into this regulatory pathway suggests a mechanism that may be 
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broadly utilized to orchestrate structural changes within presynaptic terminals. We propose that 
the regulation of DLK by PKA may be generally important for neuronal plasticity as well as 
responses to axonal damage. 
3.5 Material and methods 
3.5.1 Fly genetics 
The following fly strains were used in this study: Canton-S (WT), m12-Gal4 
(Ritzenthaler et al., 2000), BG380-Gal4 (Budnik et al., 1996), OK6-Gal4 (Aberle et al., 2002), 
RRa(eve)-Gal4 (Fujioka et al., 2003), puc-lacZ
E69
, wnd
3 
, UAS-Wnd, (Collins et al., 2006), UAS-
GFP-Wnd
KD
 (Xiong et al., 2010), UAS-PKA
CA
 (Li et al., 1995).  UAS-Wnd
S301A,S305A
 flies were 
generated from pUAST-Wnd
S301A,S305A
 plasmid for this study.  UAS-wnd-RNAi (VDRC 13786) 
and UAS-moody-RNAi (VDRC 100674) were from the Vienna RNAi center.  UAS-pka-c1-
RNAis (31277, 35196) and UAS-dnc-RNAi (27250) were acquired from Bloomington stock 
center.  
3.5.2 Nerve crush assay and immunocytochemistry in Drosophila 
Peripheral nerve crush assays in 3
rd
 instar larvae were performed according to (Xiong et 
al., 2010).  Briefly, the segmental nerves of third instar larvae were pinched and crushed by a 
fine No.5 forceps while the larvae were anesthetized with CO2 gas.  After injury, larvae were 
transferred to a grape plate and kept in 25ºC incubator for specified time periods.  
Drosophila third instar larva were dissected in ice-cold PBS and fixed in 4% 
paraformaldehyde for 25 minutes.  Antibodies were used in PBS supplemented with 0.3% Triton 
and 5% normal goat serum.  Anti-lacZ (40-1a, Developmental Studies Hybridoma Bank) was 
diluted 1:100.  Anti-dsRed polyclonal antibody (632495, Clontech) was diluted 1:1000.  For 
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secondary antibodies, A488- or Cy3-conjucated goat anti-mouse or rabbit (Invitrogen) were used 
at 1:1000.  
3.5.3 Imaging and quantification 
Confocal images were collected on an Improvision spinning disk confocal system, 
consisting of a Yokagawa Nipkow CSU10 scanner, and a Hamamatsu C1900-50 EMCCD 
camera, mounted on a Zeiss Axio Observer with 40X (1.3NA) oil objectives. Similar settings 
were used for imaging of all compared genotypes and conditions.  Volocity software (Perkin 
Elmer) was used for intensity measurements and quantification of all confocal data. 
A quantification of the sprouting response in injured motoneuron axons was 
measurement of the change of total volume of regenerating axonal membrane, labeled by mCD8-
GFP, within a 100 µm distance from the injured tip.  Pixels within the most distal 100 µm of the 
injured proximal stump were selected based on mCD8-GFP intensity criteria of >3 standard 
deviation above the mean, and then summed to measure total membrane volume.  Figure 1 and 
3F report the change in average volume at 15h after injury compared to T=0 (immediately after 
injury). 
Puc-lacZ expression was quantified by measurement of mean intensity for lacZ staining 
in the nuclei of motoneurons located along the dorsal midline (segments A3-A7) of the nerve 
cord of third instar larva.  The mean intensity of GFP-Wnd
KD
 within segmental nerves was 
quantified by measuring GFP intensity within 100 µm distance of each nerve at the site of exit  
from the ventral nerve cord.  
3.5.4 Cell culture 
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HEK293 cells were cultured in DMEM/F12 (Gibco) supplemented with 10% fetal bovine 
serum (Gibco) and 1% penicillin-streptomycin (Invitrogen). For transient transfection, 1 µg of 
given vectors were transfected into 3.5 cm dish using Lipofectmine 2000 (Invitrogen).  20 h after 
transfection, cells were processed for Western blotting.  Plasmids used for transfection were 
Flag-DLK (Huntwork-Rodriguez et al., 2013), Flag-DLK
S302A 
(Huntwork-Rodriguez et al., 2013), 
Flag-DLK
K185A
 (directly generated from Flag-DLK)  and PKA
CA
 (Merrill et al., 2011).  
3.5.5 Primary neuron culture and mouse model 
Cortical neurons were dissected from E18 rat embryos.  The cortex was digested by 
incubating with 0.5% trypsin-EDTA (Gibco) and DNAse I (Roche) at 37ºC for 10 min.  
Following digestion, neurons were washed twice in DMEM medium (Gibco) containing 10% 
FBS before resuspension in neuronal growth media which containing neurobasal (Gibco), 
Glucose (Sigma), Glutamax (Gibco), penicillin-streptomycin and B27 supplement (Gibco).  All 
the plates were coated with 100 µg/mL ploy-D-lysine (P7886, Sigma) for 2 hours. Neurons were 
then triturated and plated at a final concentration 400,000 cells/mL.   
For adult DRG experiments, DRG neurons were collected from either CD1(Charles 
River), or DLK F/F; Adv-Cre-/- (WT), or DLK F/F; Adv-Cre+/- (DLK KO) mice.  WT and DLK 
KO mice were age-sex matched.  Neurons were prepared as previously described (Frey et al., 
2015).  Briefly, DRG were digested for 15 minutes at 37ºC with 0.35 mg/mL liberase Blendzyme 
(Roche), 10mg/mL bovine serum albumin (sigma), and 0.6 mg/mL DNase (Sigma) followed by 
another 15 minutes digest at 37ºC with 0.05% trypsin.  DRG were tritterated in culture media 
(DMEM containing 10% FBS, 100 µg/mL penicillin and 100 µg/mL streptomycin) to 
dissociated cells.  Cells were plated on PDL (10 mg/mL) and laminin (10 mg/mL) coated plates.  
On day in vitro (DIV)1, half of the media was removed and fresh media containing AraC (Sigma, 
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10 nM final) was added.  Drug treatment and replating were performed as described previously 
(Frey et al., 2015).  On DIV4, DMSO or forskolin (30 µM) were added to cells.  24 hours after 
drug application, drugs were washed out with DMEM.  Neurons were lightly trypsinized with 
0.025% trypsin for 5 minutes in the incubator (37ºC, 5%CO2).  Trypsin was removed and fresh 
culture media was added to the cells which were then gently pipetted and transferred to culture 
slides.  18 hours after replating, neurons were fixed (4% PFA) and stained for βIII-tubulin 
(Covance, mouse anti-Tuj1, 1:500). At least 100 neurons were imaged per group using either 
Leica DFC310 FX or DFC7000T color fluorescence cameras and longest neurite was traced 
using NeuronJ plugin for ImageJ.  For replating experiments with PKA inhibitor (H-89, 5 µM), 
vehicle or inhibitor were added at the same time as DMSO and forskolin.  
3.5.6 Immunochemistry, antibodies and chemicals 
For detection of Wnd protein levels in larva nerve cords, the whole brains were carefully 
dissected from third instar larva.  The two brain lobes were removed before they were frozen in 
liquid nitrogen and processed for western blotting (25 nerve cords per lane).   
For western blots using HEK293 cells or cortical neurons, cells are lysed by incubating 
on ice for 10 min with RIPA buffer (Invitrogen) supplemented with Complete protease inhibitor 
cocktail (Roche) and PhosSTOP phosphatase inhibitor (Roche).  Protein concentrations were 
measured by BCA assay kit (Thermo Scientific).   
Equal amount of protein samples were loaded on each lane of NuPAGE 4-12% Bis-Tris 
gels (Invitrogen) and subject to electrophoresis separation in MOPS buffer (Invitrogen).  Blots 
were visualized with SuperSignal chemiluminescent substrate (Thermo Scientific) and exposure 
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to either film or ChemiDoc (Bio-Rad).  Bands intensities were determined using software ImageJ 
(NIH) using the gel analysis plug-in.  
The following antibodies were used for Western blotting: anti-Wnd A3-1,2 at 1:700 
(Collins et al., 2006) ; anti-DLK at 1:5000 (Huntwork-Rodriguez et al., 2013); anti-β-tubulin at 
1:1000 (E7; Developmental Studies Hybridoma Bank); anti-Flag at 1:1000 (F1804, Sigma); anti-
PKA C (catalytic subunit) antibody at 1:1000 (4782, Cell signaling); anti-phospho-cJun antibody 
at 1:1000 (3270, Cell signaling);  anti-phospho-S6K antibody at 1:1000 (9234, Cell signaling) 
and anti-S6K antibody at 1:1000 (2708, Cell signaling). 
Anti-phospho-DLK
S302
 antibodies were raised by immunization of rabbits with the 
peptide KELSDKpSTKMpSFAGTV and affinity purified before use at dilution 1:100. While the 
antibodies  were raised against a dually phosphorylated peptide (pS298, pS302), no difference in 
reactivity was noticed for DLK S298A mutants (data not shown).  
Forskolin (F6886, Sigma) was applied to either HEK293 cells or cortical neurons at the 
final concentration of 30 µM for 6 hours.  H-89 (B1427, Sigma) was used at the final 
concentration of 5 µM for cortical neurons for 6 hours.  JNK inhibitor VIII (420135, EMD 
Millipore) was used at the final concentration of 10 µM on HEK293 cells for 6 hours.  Torin1 
(4247, Tocris) or Rapamycin (LC laboratories) was applied to the cells at 1 µM (final 
concentration) for 2 hours before harvest.  
3.5.7 Protein phosphatase assay 
24 hours after transfection of the given constructs, HEK293 cells in a 6 cm dish were 
washed by ice-cold PBS and harvested in ice-cold RIPA buffer supplemented with EDTA-free 
protease inhibitor (Roche).  The cell lysates were incubated on ice for 30 minutes and 
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centrifuged at 14,000 rpm at 4ºC for 10 minutes. The soluble lysate was incubated with 3 µg 
anti-Flag antibody pre-bound with 15 µl Dynabeads Protein G (Novex) for 1 hour at 4ºC.  After 
removal of supernatants the beads were washed 3 times with RIPA buffer, and then incubated 
with 1X PMP buffer (NEB), 1X MnCl2 (NEB) and either 1000 U lambda protein phosphatase 
(NEB) or equal amount of glycerol (control) in RIPA buffer for 30 minutes at 30ºC.  Beads were 
then removed from the reaction buffer and FLAG-DLK was eluted by boiling in SDS sample 
buffer for 10 minutes.  Equal amount of samples were analyzed by western blot.  
3.5.8 In vitro PKA kinase assay 
HEK293 cells transfected with Flag-DLK were washed by ice-cold PBS and harvested 
using ice-cold cell lysis buffer (50 mM Tris-HCl, pH7.5, 150 mM NaCl, 1 mM EDTA, 1% 
Triton X-100, Complete protease inhibitors (Roche) and 30 µM MG132 (Sigma)). Flag-tagged 
DLK was immunoprecipitated from HEK293 cell lysates using anti-Flag M2 antibody (Sigma) 
and Protein G Dynabeads (Novex).  The DLK-bound beads were then washed with 3X lysis 
buffer and incubated with 2,000 U lambda protein phosphatase (NEB) for 30 min at 30ºC to 
remove all the phosphate groups. After incubation, the beads were washed with wash buffer 
containing cocktail phosphatase inhibitor (Roche) and split equally into two tubes containing 
kinase reaction buffer (50 mM Hepes, pH7.2, 10 mM MgCl2, 0.01% Triton X-100, 2 mM DTT, 
and 30 µM ATP).  10,000 U recombinant human full length PKA catalytic subunit alpha (NED 
Millipore) was added to one of the tubes, while the control tube were added with glycerol.  Both 
tubes were incubated at 30ºC for 90 min.  Flag-DLK was eluted from beads by boiling in the 
SDS sample buffer.  Equal amounts of samples were analyzed by western blotting with anti-
DLK and anti-pDLK
S302
 antibodies.  
3.5.9 Statistical analysis 
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For experiments in flies, we knew from previous work that a sample size of 10 animals 
per genotype was large enough to detect significant differences among genotypes (Xiong et al., 
2010, Xiong et al., 2012).  Therefore, at least 10 animals (≥ 50 axons) were examined and 
quantified in each genotype.  Each experiment was repeated at least 3 times with independent 
biological replicates.  For experiments in mice, we knew from previous work that measuring 100 
neurons per genotype and an N=3-4 was sufficient to detect reproducible differences between the 
experimental groups (Frey et al., 2015, Valakh et al., 2015).  Therefore, all the experiments were 
performed with at least 3 independent biological replicates.  
One way ANOVA and multiple comparisons were conducted when more than two 
samples are compared. Tukey post-hoc test was used to correct for multiple comparisons.  For 
binned DRG neurites length distribution, statistical significance was determined by two way 
ANOVA followed by Bonferroni post-hoc test.  p values smaller than 0.05 were considered 
statistically significant.  All p values are indicated as * p < 0.05, ** p < 0.01, and *** p < 0.001 
and **** p<0.0001.  Data are presented as mean ± SEM. 
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3.6 Figures 
Figure 3.1 
 
 
Figure 3.1 PKA stimulates and is required for axonal regeneration in Drosophila 
motoneurons. 
Single motoneuron axons were labeled by expression of UAS-mCD8-GFP using the m12-Gal4 
driver and imaged either 0 hour or 15 hours after nerve crush injury.  Representative images are 
shown in (A), while (B) shows quantification of the increased volume in axonal membrane, 
which is measured within 100 µm of the proximal axon tip, indicated in dotted line.  Genotypes 
used in (A): WT(;;m12-Gal4, UAS-mCD8GFP/+); control-RNAi (UAS-dcr2;; UAS-moody-
RNAi/m12-Gal4, UAS-mCD8GFP); dnc-RNAi (UAS-dcr2;; UAS-dnc-RNAi/m12-Gal4,UAS-
mCD8GFP); wnd-RNAi (UAS-dcr2;; UAS-wnd-RNAi/m12-Gal4,UAS-mCD8GFP); PKA
CA
(; 
UAS-PKA
CA
/+; UAS-mCD8GFP/+); PKA
CA
,control-RNAi (UAS-dcr2; UAS-PKA
CA
/+; UAS-
moody-RNAi (VDRC 100674)/m12-Gal4, UAS-mCD8GFP); PKA
CA
,wnd-RNAi (UAS-dcr2; 
UAS-PKA
CA
/+; UAS-wnd-RNAi/m12-Gal4, UAS-mCD8GFP); pka-c1-RNAi (UAS-dcr2; UAS-
pka-c1-RNAi/+; m12-Gal4, UAS-mCD8GFP (using two different lines, Bloomington 31277 and 
35169)).  All data are represented as mean ± SEM; At least 10 animals (≥50 axons) are examined 
per genotype; *** P<0.001; ‘n.s.’ indicates non-significant; scale bar, 100 μm.  
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Figure 3.2 
 
 
Figure 3.2 PKA modulates the levels of Wnd protein and downstream signaling in 
Drosophila motoneurons. 
(A) The puc-lacZ transcriptional reporter for Wnd/JNK signaling indicates that activated PKA 
stimulates Wnd signaling.  A pan-neuronal driver (BG380-Gal4) is used to express UAS-dnc-
RNAi, UAS-PKA
CA
 or UAS-PKA
CA
 together with UAS-wnd-RNAi or a control-RNAi. Example 
images are shown of cell bodies in the dorsal midline of the ventral nerve cord; (all but two of 
these neurons are motoneurons).  Quantification (described in methods) was carried out for 10 
animals per genotype.   
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(B) Endogenous Wnd protein levels are increased in PKA
CA
 expressing neurons.  Ventral nerve 
cords were dissected from third instar larvae (BG380-Gal4 [WT control] and BG380-Gal4; 
UAS-PKA
CA
/+) and processed for Western blotting with anti-Wnd and anti-tubulin antibodies.  
The quantification shows Wnd/tubulin ratios (normalized to WT control) averaged from 3 
independent experiments (25 nerve cords per experiment).  
(C) PKA increases DLK levels via a posttranscriptional mechanism.  GFP-tagged kinase dead 
Wnd (GFP-Wnd
KD
) was ectopically expressed using m12-Gal4 driver (WT control) or co-
expressed with UAS-PKA
CA
 and imaged directly after fixation.  Example images and 
quantification of GFP-Wnd
KD
 intensity in cell bodies and axons within segmental nerves.  n>10 
animals for each condition.  
(D) PKA-C1 is required for induction of Wnd protein after axonal injury.  Example images and 
quantification of GFP-Wnd
KD
 in nerve cords and segmental nerves before and after (8 hours) 
injury.  UAS-GFP-Wnd
KD
 was expressed in motoneurons by OK6-Gal4.  WT or together with 
UAS-pka-c1-RNAi or UAS-moody-RNAi (control) and imaged similarly to Figure 2C.  The 
quantification method for GFP intensity is described in materials and methods. n>10 animals for 
each condition.  
All data are represented as mean ± SEM; *** P<0.001, ** P<0.01, *P<0.05, ‘n.s.’ indicates non-
significant; scale bars, 10 μm.  
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Figure 3.3 
 
Figure 3.3 PKA activates DLK via phosphorylation of its activation loop. 
(A-B) Changes in endogenous DLK abundance in response to treatment with forskolin (30 µM) 
(A) or the PKA inhibitor H-89 (5 µM) (B) for 6 hours in cultured rat embryonic cortical neurons.  
Quantification shows relative DLK/Tubulin levels in western blots. 
(C) Alignment of activation loop sequences in different species.  
(D) The anti-pDLK
S302
 antibodies recognize transfected Flag-DLK
WT
, but not activation loop 
mutation Flag-DLK
S301A,S305A
.  Both proteins were transiently expressed in HEK293 cells.  
Western blots were probed with anti-pDLK
S302
 antibody, anti-Flag antibody to detect the total 
DLK expression levels, and anti-Tubulin (which remains similar in all manipulations) for 
normalization.  
(E) PKA
CA
 stimulates phosphorylation of DLK S302 in HEK293 cells.  HEK293 cells were co-
transfected with Flag-tagged DLK
WT
 and an empty control plasmid or PKA
CA
.  Cell lysates were 
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probed with anti-DLK antibody, anti-pDLK
S302
 antibody, anti-PKA C antibody and anti-tubulin 
antibody.  
(F) PKA
CA
 stimulates an increase in DLK molecular weight. FLAG-DLK protein was 
immunoprecipitated from HEK293 cells co-transfected with DLK and either Flag-tagged DLK
WT
 
and an empty control plasmid or PKA
CA
. The immunoprecipitated FLAG-DLK was then 
incubated with either glycerol (control) or lambda protein phosphatase (λPP). PKACA induced a 
upward shift in DLK molecular weight, which was lost upon phosphatase treatment. 
(G) The activation loop is required for axonal regeneration in Drosophila neurons.  Single axons 
in Drosophila third instar larva are labeled by mCD8RFP using eve-Gal4 driver.  24 hours after 
injury, these neurons in animals heterozygyous for wnd (wnd
3
/+) show robust axonal sprouting.  
However, sprouting fails to occur in wnd
3
/wnd
3
 animals.  Expression of UAS-Wnd (WT) can 
restore axonal regeneration in wnd mutant background (UAS-Wnd, wnd
3
; wnd
3
,eve-Gal4, UAS-
mCD8RFP).  However, expression of activation loop mutant UAS-Wnd
S301A,S305A
 failed to 
rescue the sprouting defect in wnd mutant animals (UAS-Wnd
S301A,S305A
, wnd
3
; wnd
3
, eve-
Gal4,m12-mCD8RFP).  Quantification of the volume of axonal membrane within 100 µm of the 
distal ending of the proximal stump.  n> 50 axons for each genotype. Data are presented as mean 
± SEM for 3 independent experiments; *** P<0.001; scale bar, 100 µm. 
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Figure 3.4 
 
Figure 3.4 PKA promotes the stability of DLK independently of DLK downstream 
signaling. 
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(A-B) Activation of PKA promotes DLK stability independently of JNK. HEK293 cells were 
transiently transfected with Flag-DLK
WT
, and (A) treated with forskolin (6 hours, 30 µM) or (B) 
co-transfected with either PKA
CA
 or empty vector (control).  In both cases, co-treatment with 
JNK inhibitor VIII (10 µM, 6 hours) led to a decrease in total Flag-DLK levels.  However, both 
forskolin and PKA
CA 
induced an increase in DLK levels even in the presence of JNK inhibitor.    
Quantification shows average total DLK/Tubulin intensities and average pDLK
S302
/total DLK 
ratios (where total DLK is detected using anti-Flag antibody).  All data are represented as mean 
± SEM; quantifications of relative intensity from Western Blots were averaged from 3 
independent experiments; *** P<0.001, ** P<0.01, *P<0.05, ‘n.s.’ indicates non-significant. 
(C-D) Activation of PKA increases the stability of kinase dead DLK mutants, DLK
K185A
 (C) and 
DLK
S302A 
(D).  HEK293 cells were transiently transfected with Flag-DLK
K185A 
or Flag-DLK
S302A
 
together with PKA
CA
 or empty plasmid.  Treatment JNK inhibitor VIII (10 µM) for 6 hours had 
no effect upon the  PKA
CA
 induced levels of DLK
K185A
 and DLK
S302A 
mutant protein. 
Quantifications are similar to Figure 4A-B. Western bands intensity were averaged from 4 
independent experiments; data are shown as mean±SEM; *** P<0.001, ** P<0.01, *P<0.05, 
‘n.s.’ indicates non-significant. 
(E) Proposed model for the activation and stabilization of DLK by cAMP and PKA. cAMP 
elevation and PKA activation leads to the phosphorylation of S302 on DLK, which activates its 
kinase activity. Indicated in the blue arrow, downstream signaling via JNK leads to enhanced 
DLK stability and phosphorylation of DLK at other sites (Huntwork-Rodriguez et al., 2013). 
PKA also enhances DLK’s stability via an additional mechanism that is independent of S302 
(red arrow).  
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Figure 3.5 
 
Figure 3.5 PKA stimulates axonal regeneration via DLK in adult DRG neurons. 
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(A-D) Induction of regeneration by forskolin requires PKA.  Experimental design (A and also 
see Materials and Methods). To demonstrate that forskolin-induced neurite outgrowth is 
mediated by PKA, we assessed whether PKA signaling was required using the PKA inhibitor H-
89 (PKAi, 5 µM).  Representative neurons are shown in (B).  Neurite outgrowth was assessed by 
quantifying mean neurite length (C) and distribution of longest neurite (D).  Data are mean ± 
SEM for 4 independent experiments. 
(E-G) Induction of regeneration by forskolin requires DLK. WT and DLK KO neurons were 
treated with DMSO or forskolin (30 µM) as described in (A). Representative neurons are shown 
in (E).  Neurite outgrowth was assessed by quantifying mean neurite length (F) and distribution 
of the longest neurite (G).  Data are mean ± SEM for 3 independent experiments. 
*** P<0.001, ** P<0.01, *P<0.05, ‘n.s.’ indicates non-significant; scale bars, 100 µm. 
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Figure 3.6 
 
Figure 3.6 PKA can directly phosphorylate DLK at S302. 
(A) PKA can induce DLK S302 phosphorylation in vitro.  Flag-DLK was purified from HEK293 
cells by anti-Flag immunoprecipitation and used for an in vitro kinase activity with purified PKA 
catalytic subunit. 5 µg of purified DLK was incubated with or without 10,000 U PKA catalytic 
subunit.  Equal amounts of DLK in both samples (as demonstrated by probing with anti-DLK 
antibody) were analyzed by western blotting with anti-pDLK
S302
 antibody.  (B) Quantification 
shows relative pDLK
S302
/total DLK levels.  
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Figure 3.7 
 
Figure 3.7 DLK activation by PKA does not require TORC1. 
(A-B) The phosphorylation level of DLK S302 is not sensitive to treatments of TORC1 
inhibitors.  HEK293 cells were either untransfected or transfected with Flag-DLK
WT 
+ empty 
plasmid or Flag-DLK
WT 
+ PKA
CA
. Cells were treated with torin1 (A) or rapamycin (B) for 2 
hours.  The efficiency of the drugs were demonstrated by probing with anti-phospho-S6K 
antibody.  
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Figure 3.8 
 
Figure 3.8 Summary of predicted PKA phosphorylation sites on DLK/Wnd in different 
species. 
The sequence of DLK homologues in different species (human, mouse, Drosophila and C. 
elegans) were analyzed by Group-based Prediction System (GPS) to computationally predict 
PKA phosphorylation sites (Xue et al., 2008, Xue et al., 2005).  Identified potential PKA
CA
 
phosphorylation motifs in different species are shown, with the phosphorylation site highlighted 
in red. Numbering is shown for mouse DLK. Two sites, S302 and S389, are conserved among all 
the species.   Other sites are conserved in mammals, while fly DLK has a similar number of sites 
but in distinct locations. Not shown, C. elegans DLK also has 11 additional predicted sites, but at 
distinct locations from mammalian and fly DLK.  
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Chapter 4 :  
Raw is required for axonal degeneration after injury 
 
4.1 Abstract 
Axonal degeneration after injury is self-destruction process that results in widespread 
axon breakdown and functional loss. Despite great interest, this process is still poorly understood. 
In this study, we have identified the Drosophila transmembrane protein Raw as an important 
mediator of axonal and synapses degeneration. In raw mutants, axons and synapses of both 
motoneurons and sensory neurons remain intact and fail to degenerate after peripheral nerve 
injury. We show that Raw functions cell autonomously to regulate susceptibility to degeneration 
by antagonizing the function of the AP-1 transcription factor. Although the NAD+ synthetic 
enzyme nicotinamide mononucleotide adenylyl transferase (Nmnat) has previously been 
implicated in axonal degeneration, knockdown of nmnat in motoneurons in raw mutant 
background only very modestly affects the protective effect. Thus, our study suggests a novel 
mechanism through which axonal degeneration is regulated.   
4.2 Introduction 
Axonal degeneration is morphologically characterized by catastrophic fragmentation of 
the entire axonal cytoskeleton and membrane. Acute axonal transection (also termed ‘axotomy’) 
represents a severe axonal damage and results in the degeneration of the axon stump distal to the 
injury site, called Wallerian degeneration. Wallerian degeneration is not only morphologically 
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similar to axon degeneration in many neurodegenerative diseases and neuropathies, but also 
shares similar molecular mechanisms  (reviewed in (Wang et al., 2012a, Coleman and Freeman, 
2010)). Wallerian degeneration occurs via a cell-autonomous ‘self-destruction’ pathway, whose 
molecular components and their associated cellular functions are still in the process of being 
identified. Hence the cellular mechanism by which injured  axons and synapses degenerate is 
still poorly understood. 
Previous studies have implicated a role for the E3 ubiquitin ligase Highwire (Hiw) in 
Wallerian degeneration: axonal degeneration is significantly delayed in hiw mutant animals 
(Xiong et al., 2012, Neukomm et al., 2014, Babetto et al., 2013). Hiw modulates axon 
degeneration via down-regulating the NAD+ synthetic enzyme nicotinamide mononucleotide 
adenylyl transferase (Nmnat). Nmnat has been demonstrated to play a central role in axon 
degeneration. Studies in multiple organisms suggest that Nmnat strongly protects axons from 
degeneration after injury (Sasaki et al., 2009, Gilley and Coleman, 2010, Fang et al., 2012, Milde 
et al., 2013, Sasaki et al., 2016). Nmnat is considered to be a ‘survival factor’ in axons, since 
knockdown of nmnat leads to spontaneous axon degeneration (Gilley and Coleman, 2010). How 
does Nmnat protect axon from degeneration? A recent study suggest that it can inhibit the 
function of Sarm1 (Sasaki et al., 2016), which was identified as a crucial mediator of axonal 
degeneration (Osterloh et al., 2012). However, it is not clear that whether this is the only 
pathway that regulates axonal degeneration.  
Studies using the model organism Drosophila have identified several new genes 
important for axon degeneration, illustrating the power of genetics and significantly influencing 
our understanding of this degeneration process. To study axonal injury signaling, we have 
previously established a Drosophila larval nerve crush assay, in which injured axons undergo a 
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highly stereotyped degeneration process (Xiong and Collins, 2012). Using this model, we have 
identified a mutation on the second chromosome that strongly inhibits axon degeneration in vivo, 
and have mapped this mutation via whole genome sequencing to the Drosophila gene raw. Raw 
is previously known as a negative regulator of JNK signaling via the AP-1 transcription factor 
during embryonic dorsal closure and gonad development (Jack and Myette, 1997, Byars et al., 
1999, Bates et al., 2008, Jemc et al., 2012). Here we find AP-1 is an important mediator of the 
regulation of axonal degeneration by Raw. Therefore, Raw not only functions during 
development, but also appears to be a crucial component of the axonal degeneration machinery.  
4.3 Results 
4.3.1 Identification of an unexpected mutation that strongly protects injured axons from 
degeneration in Drosophila 
Caspases, which are important mediators programmed cell death, are suggested to be 
involved in axonal pruning during development (Simon et al., 2012). Previous studies suggest 
that Wallerian degeneration involves mechanisms that are molecularly distinct from apoptosis 
(Finn et al., 2000), so we were surprised to notice that in null mutant animals for the dcp-1 
caspase, (dcp-1
Prev1
),  axonal degeneration was strongly inhibited. To assess the degeneration of 
motoneuron axons, we used the m12-Gal4 driver to label only two neurons per hemi-segment 
with membrane-bound mCD8-GFP.  Within 20 hours after nerve crush injury, axons in wild type 
(WT) animals were completely fragmented (Figure 4.1A and B).  In contrast, injured 
motoneuron axons in dcp-1Prev1 animals remained completely intact even 2 days after injury 
(Figure 1A and B). Degeneration at the synaptic neuromuscular junction (NMJ) terminal was 
also inhibited in the dcp-1
Prev1
mutant (Figure 4.1B). In WT animals, the axonal membrane, 
labeled by anti-HRP antibodies, becomes fragmented within 20 hours after injury, and the 
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microtubule binding protein MAP1B homologue Futsch, disappears completely from the NMJ 
boutons (Figure 4.1B). In contrast, in dcp-1
Prev1 
line, both markers remained intact 20 hours after 
injury (Figure 4.1B). We also observed that class IV Da sensory neuron axons, which were also 
injured in the segmental nerve crush assay and could be labeled ppk-Gal4 driven membrane-
bound GFP, failed to degenerate in dcp-1
Prev1 
 mutants (Figure 4.1C).  
Importantly, further genetic analysis of the dcp-1
Prev1
 line led to the finding that the 
degeneration phenotype was caused by a new mutation in the dcp-1Prev1 strain background. 
First we noticed that other alleles of dcp-1 (Etchegaray et al. 2012) had no effect on larval NMJ 
degeneration (Figure 4.6A and B). Then we noticed that the dcp-1
Prev1 
mutation was not linked to 
the degeneration phenotype: out of 13 recombinant lines that contained the dcp-1
Prev1
 mutation, 
none were able to elicit the degeneration phenotype of the founder strain (Figure 4.6A and B).  
4.3.2 Axonal degeneration in dcp-1
Prev1 
is caused by a mutation in raw 
 The dcp-1
Prev1
 line was originally generated by an imprecise P-element excision of a P-
element insertion (k05606), which is inserted within the first exon in the dcp-1 gene (Laundrie et 
al., 2003). The parental line k05606, which is also a dcp-1 null mutant, does not have an axon 
degeneration phenotype (Figure  4.6A and B). We therefore inferred that the new mutation could 
be identified as a variant between k05606 line and dcp-1
Prev1
 line. We used next-generation 
sequencing technology to sequence the whole genome of dcp-1
Prev1
, the parental line k05606, 
and compared variants with three dcp-1
Prev1
 recombinant lines which did not have the 
degeneration phenotype. Candidate mutations that inhibit degeneration should only be present in 
the sequence of dcp-1
Prev1
, but not in the parental or recombinant lines. Based on these criteria, 
we identified 332 variants. After annotation of these variants to genes, we focused on non-
synonymous variants and identified 6 candidate genes  (Table 4.1). We obtained small 
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chromosome deficiencies for each and tested by complementation whether the deficiency could 
unveil the degeneration phenotype as a transheterozygote with dcp-1
Prev1
 (Table 4.1). This was 
the case for one of the deficiencies Df(2L)BSC204 (from 29D5 to 29F8) which uncovers 
mutations in the candidate gene  raw (29E4-29E6) (Figure 2A and B).  
To test the role of Raw in axon degeneration, we tested two previously identified raw 
mutants (raw
134.47
 and raw
155.27
) (Jemc et al., 2012). As both of these EMS-generated mutations 
are homozygous lethal, we examined the trans-heterozygous raw
134.47
/ dcp-1
Prev1
 and raw
155.27
/ 
dcp-1
Prev1
 and found that NMJ degeneration is strongly inhibited (Figure 4.2A and B). Together 
with rescue data described below, we infer that the mutation of interest in the dcp-1
Prev1
  mutant 
background is a mutation in raw, for further reference we named this mutation raw
dcp-1
. 
4.3.3 Raw promotes axonal degeneration in Drosophila neurons 
Based on the sequencing data, we noted that the raw
dcp-1 
allele contains a missense 
mutation in raw open reading frame. Interestingly, this point mutation A532D is within the 
predicted EF hand of Raw (Figure 4.2C). Raw is known to play multiple important roles during 
development. It regulates embryo dorsal closure and gonad morphogenesis (Jemc et al., 2012, 
Byars et al., 1999, Jack and Myette, 1997). Therefore, most of the raw mutants are embryonic 
lethal. Since raw
dcp-
 
1 
mutants are viable and fertile, and the degeneration phenotype is recessive, 
we suspect that the raw
dcp-1 
 mutations confer a partial loss in raw function. To test this and to 
determine of the cellular locus of Raw’s function in degeneration, we carried out both RNAi 
knockdown and rescue experiments. Using the Gal4/UAS system, we drove expression of UAS-
Raw-RA and Raw-RB (two different isoform of Raw). Expression of either isoform via the 
single motoneuron m12-Gal4 driver was sufficient to fully revert axon degeneration phenotype 
of raw
dcp-1 
mutants (Figure 4.2D and E). Moreover, expression of Raw using a motoneuron 
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driver D42-Gal4 can revert the NMJ degeneration phenotype of raw
dcp-1
 mutants (Figure 4.2A 
and B). In contrast, expression of Raw in glia using repo-Gal4 failed to rescue the phenotype 
(Figure 4.2A and B), arguing that Raw is play a cell-autonomous role in neurons to promote 
axon degeneration. In further support of this, knockdown of Raw by UAS-Raw-RNAi lines using 
m12-Gal4 also strongly inhibits axon degeneration (Figure 4.2D and E). Together, these data 
indicate that Raw is required in larval neurons to drive axon degeneration after injury.  
4.3.4 Knockdown of nmnat only modestly affects the axonal protective effect of Raw 
The strong raw loss-of-function phenotype strikingly resembles the loss-of-function 
phenotype of Hiw in their ability to delay axonal degeneration (Xiong et al., 2012). Previous 
studies suggest that Hiw promotes axonal degeneration by promoting the turnover of Nmnat, a 
key protective factor in axons (Xiong et al., 2012, Babetto et al., 2013). We therefore wondered 
whether Raw regulates axon degeneration by promoting an increase in Nmnat levels and/or 
function. To test this, we used UAS-nmnat-RNAi to knockdown nmnat in motoneurons. This 
knockdown is effective as demonstrated by the immunostaining with anti-Nmnat antibodies in 
our previous studies (Xiong et al., 2012). nmnat-RNAi mediated knockdown of nmnat using 
m12-Gal4 driver did not affect development, but leads to a modest enhancement to the rate of 
axonal degeneration after injury (Figure 4.3B). As it is shown in Figure 3B and our previous 
study (Xiong et al., 2012), knockdown of nmnat in motoneurons significantly rescued the axon 
degeneration phenotype in hiw mutants. In contrast, knockdown of nmnat using the same driver 
m12-Gal4 only very modestly affects the suppression of axon degeneration in raw
dcp-1
 mutant 
(Figure 4.3A and B). Consistent with this, while knockdown of nmnat in motoneurons 
suppressed the NMJ protective phenotype in hiw mutant (Figure 4.3F and (Xiong et al., 2012)), it 
has little effect on the NMJ degeneration phenotype in raw mutant (Figure 4.3F).   
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As a survival factor in axons, the axonal protective effect of Nmnat is associated with its 
level in axons (Xiong et al., 2012, Gilley and Coleman, 2010, Fang et al., 2012). Endogenous 
Nmnat level is not detectable in neurite-rich neuropil in WT animals, but it increased 
dramatically hiw mutant animals (Figure 4.3C and D). However, we cannot detect any increase 
of Nmnat level in the neuropil of raw
dcp-1
 animals (Figure 4.3C and D). Surprisingly, we 
observed dramatic increase of Nmnat level in glia wrapping segmental nerves (Figure 4.3E), 
which made us wonder whether Nmnat in glia affected axon degeneration. To test this, we use 
the glia specific driver repo-Gal4 to knockdown Nmnat in the glia. However, we found that even 
when Nmnat level is significantly reduced in glia, NMJ degeneration in raw
dcp-1
 animals is still 
strongly protected from degeneration (Figure 4.3F and G). Thus, the elevated Nmnat level in glia 
in raw
dcp-1
 mutant is not crucial for the delay of axon degeneration phenotype. Together, we 
conclude that Raw might mediate axonal degeneration independently of Nmnat.  
4.3.5 Raw regulates axonal degeneration via AP-1 
Previous studies suggest that Raw regulates dorsal closure and gonad morphogenesis 
through down-regulation of the c-Jun N-terminal kinase (JNK) signaling cascade (Jemc et al., 
2012). Consistent with these studies, we found that the Puckered reporter puc-lacZ, which 
contains lacZ enhancer trap for the JNK downstream phosphatase Puckered, is strongly activated 
in neurons when UAS-raw-RNAi was expressed using a pan-neuronal driver BG380-Gal4 
(Figure 4.4A), suggesting that Raw is a negative regulator of JNK signaling in neurons.  
Importantly, JNK signaling has also been intensively studied as an axonal injury 
signaling pathway (Yang et al., 2015, Shin et al., 2012b, Miller et al., 2009, Xiong and Collins, 
2012). In fact, our previous study suggested that the puc-lacZ can be used as a reporter for injury 
signaling. In WT animals, puc-lacZ expression level increased by 3-fold 24 hours after injury 
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(Figure A and (Xiong et al., 2010)). Interestingly, comparing to uninjured raw
dcp-1
 animals, 
which have a higher basal puc-lacZ expression level, injury also induced a 3-fold increase of 
puc-lacZ expression (Figure 4.4 A and B). Therefore, it seems that the increased basal JNK 
signaling in raw
dcp-1
 does not affect the axonal injury response reported by puc-lacZ. We then 
wondered whether the elevated JNK signaling contributed to the delayed axon degeneration in 
raw
dcp-1
 animals. To directly test this, we expressed a dominant negative form of JNK (JNK
DN
) 
using the UAS/Gal4 system in motoneurons in raw mutants. As reported previously, JNK
DN
 also 
causes an inhibition to degeneration, however this phenotype was not as strong as the raw mutant 
phenotype. Strikingly, even while JNK
DN
 inhibits degeneration on its own, it caused a modest 
increase in degeneration in the raw mutants and the appearance of varicosities within axons 
which typically occurs as a precursor to complete degeneration (Figure 4.4C and D).  This 
suggests that JNK might play dual roles in axonal degeneration: it promotes axonal degeneration 
in WT animals, whereas it also plays a protective role in Raw mediated axonal degeneration. 
Indeed, previous studies suggest that JNK is required both for axonal degeneration and 
maintenance of axonal integrity (reviewed in (Coffey, 2014)).  
Raw is also suggested as a negative regulator of transcription factor Fos/Jun (activator 
protein 1, AP-1)  (Bates et al., 2008). Intriguingly, we and others have previously demonstrated 
that Fos is involved in axonal injury signaling and required for the axonal protection effects by a 
conditioning lesion (Xiong et al., 2010, Xiong and Collins, 2012). We therefore tested whether 
Fos and Jun are required for the protection by Raw. Neither expression of a dominant negative 
form of Fos (Fos
DN
) or Jun (Jun
DN
) in motoneurons in a WT background affect axonal 
degeneration (Figure 4D). However, expression of either Fos
DN
 or Jun
DN
 in the raw
dcp-1
 
background significantly rescued the degeneration phenotype (Figure 4.4C and D). We noticed 
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that neither Fos
DN
 or Jun
DN
 can fully revert the protection in raw
dcp-1
 animals. We think this is 
likely due to the inefficiency of expression Fos
DN
 or Jun
DN
 to completely inhibit AP-1. It is also 
possible that Raw also regulates axonal degeneration via additional mechanisms. We therefore 
conclude that Raw protects axon degeneration, at least partially, through the downstream 
transcription factor AP-1.   
4.4 Discussion 
Since the discovery of the gain-of-function mutation WldS which delays Wallerian 
degeneration for weeks in mammals, many studies have been focused on identifying loss-of-
function mutants to better understand the molecular mechanisms of this self-destruction axon 
death program. In this study, we identified Raw as a novel regulator of axon degeneration in 
Drosophila. We have demonstrated that a hypermorph allele of raw strongly suppressed 
Wallerian degeneration in Drosophila larvae for days. We have further showed that Raw 
promotes axonal degeneration via a pathway that involves transcription factor AP-1. 
Interestingly, although Nmnat has been thought as a central regulator of axonal degeneration, 
knockdown of Nmnat appears only very modestly affect the axonal protective phenotypes in raw 
mutants. Therefore, our studies provide a potential novel mechanism of axonal degeneration, 
which might function in parallel with Nmnat signaling. Identification of additional Raw 
interacting partners would provide more insights into the relationships of these signaling 
pathways.  
Raw and its ortholog olrn-1 in C.elegans are both neuronal expressed proteins which 
show localization in axons, dendrites and cell bodies (Bauer Huang et al., 2007, Lee et al., 2015). 
The C.elegans homologue olrn-1 contains multiple transmembrane domains and genetically 
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interacts with calcium signaling pathways (Bauer Huang et al., 2007). In Drosophila, a recent 
study characterized Raw as a single transmembrane protein with a large extracellular domain 
which contains a predicted EF hand (Lee et al., 2015), but the multiple transmembrane domains 
in olrn-1 are not present in Raw. Interestingly, the raw
dcp-1
 allele that we have identified has a 
point mutation within the EF hand (Figure 4.2). As calcium influx upon axotomy plays a critical 
role in axonal degeneration (reviewed in (Wang et al., 2012a)), it would be interesting know 
whether Raw is regulated by calcium signaling in modulating axonal degeneration.  
Previous studies suggest that Raw regulates cell-cell interactions in several 
developmental events, including dorsal closure, gonad morphogenesis and dendrite patterning 
(Jack and Myette, 1997, Byars et al., 1999, Bauer Huang et al., 2007, Bates et al., 2008, Jemc et 
al., 2012, Lee et al., 2015). It is possible that Raw mediates axon degeneration via interaction 
with an extracellular signal, which might from glia, since glia have been suggested to play a role 
in axon degeneration (Purice et al., 2016). Indeed, a recent study demonstrated disrupted glia-
axon interaction leads to axon degeneration (Takagishi et al., 2016, Xiao et al., 2015a).   
Although Raw does not have an obvious homolog in mammals, its downstream 
molecules JNK and transcription factor AP-1 are both evolutionarily conserved. JNK and its 
upstream kinase Wallenda (Wnd, DLK in mammals) are activated by axonal injury and actively 
transported in axons to mediate a retrograde signal to cell bodies (Xiong et al., 2010, Zrouri et al., 
2004, Lindwall and Kanje, 2005). Our previous studies suggest that an axonal conditioning 
lesion can protect axons from degeneration after further injury, and the protective effect is 
Wnd/DLK and Fos dependent (Xiong and Collins, 2012). As an important downstream kinase of 
Wnd and upstream kinase of Fos, it is very likely that JNK is also involved in this axonal 
protection. However, how JNK and Fos mediate this protective effect is not clear. In the present 
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study, we have identified Raw functions upstream of JNK and Fos to regulate axonal 
degeneration, suggesting that loss-of-function of raw could mimic the conditioning lesion effects. 
Dissection of the molecular mechanism by which Raw modulates JNK and Fos might enrich our 
understanding of the protective effect of the conditioning lesion. 
Studies in both Drosophila and mammals suggested that transcription factor AP-1 is 
regulated by neuronal activity (Vonhoff et al., 2013, Tuvikene et al., 2016, Morgan et al., 1987). 
Intriguingly, we have previously suggested that neuronal silencing delays axonal degeneration 
(Mishra et al., 2013). It is therefore possible that Raw regulates axonal degeneration in a pathway 
that involves neuronal activity. Since the basic molecular mechanisms of Wallerian degeneration 
is highly conserved between Drosophila and mammals (reviewed in (Rooney and Freeman, 2014, 
Neukomm and Freeman, 2014)), understanding the mechanisms for Raw would shed light on our 
understating and treatment for nerve damage in vertebrates.  
4.5 Material and methods 
4.5.1 Fly Stocks 
The following strains were used in this study: Canton-S (WT), dcp-1
prev1
 (raw
dcp-1
) 
originally from (Laundrie et al., 2003), k05606 (10390), repo-Gal4 (7415) and second 
chromosome deficiencies from Bloomington fly stock center, raw
134.47
, raw
155.27
, UAS-Raw-RA 
and UAS-Raw-RB  from (Jemc et al., 2012), hiw
ND8
 and hiw
ΔN
 from (Xiong et al., 2012) m12-
Gal4 (P(Gal4)
5053A
) (Ritzenthaler et al., 2000), BG380-Gal4 (Budnik et al., 1996), ppk-Gal4 
(Kuo et al., 2005), D42-Gal4 (Sanyal, 2009), UAS–dcr2 (a gift from Stephen Thor), UAS-JNKDN 
(Weber et al., 2000), UAS-Fos
DN
 (Eresh et al., 1997), UAS-Jun
DN
 (Eresh et al., 1997). UAS-
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nmnat-RNAi (32255), UAS-raw-RNAi (KK) (101255) and UAS-raw-RNAi (GD) (7727) were 
from the Vienna RNAi center.  
4.5.2 Larval nerve crush assay and immunocytochemistry 
The nerve crush assay was previously described in details in (Xiong et al., 2010, Xiong et 
al., 2012, Hao et al., 2016). Briefly, wandering 3
rd
 instar larvae were anesthetized with CO2 gas, 
and the segmental nerves were pinched and crushed by a shape No.5 forceps. After the crush, 
larvae were kept on a grape plate in 25°C incubator for specified time periods.  
Drosophila larvae were dissected in ice-cold PBS and then fixed in 4% paraformaldehyde 
for 25 minutes. After fixation, the samples were incubated in blocking buffer (PBS with 0.3% 
Triton and 5% normal goat serum) for 30 minutes at room temperature. Primary antibodies were 
used at the following concentrations: ms anti-Futsch (22c10, developmental studies hybridoma 
bank (DSHB)) 1:100, ms anti-lacZ (40-1a, DSHB) 1:100, guinea pig (gp) anti-Nmnat (gift from 
Grace Zhai) 1:1000. For secondary antibodies, Cy3-Gt anti-HRP (from Jackson labs) were used 
at 1:1000, A488-Gt anti-mouse or A488-Gt anti-gp (Invitrogen) were used at 1:1000.  
4.5.3 Analysis of whole genome sequencing data 
The sequences were aligned to reference Drosophila melanogaster genome (DM3) using 
Burrows-Wheerler Alignment tool (BMA). Reads that map to multiple locations were removed. 
Samtools was used to call variants. There are 332 variants that fit the criteria (homozygous 
mutation in raw
dcp-1
, heterozygous mutation in raw
dcp-1
/k05606 and homozygous wild-type in all 
three recombinant lines). These variants were then annotated to genes using software SnpEff and 
only non-synonymous mutations were kept as candidates.  The 6 candidate genes were raw, eya, 
msp-300, CG10874, CG9525 and CG17211 (summarized in Table 4.1).  
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4.5.4 Imaging  
All the confocal images were collected on an Improvision spinning disk confocal 
microscope, consisting of a Hamamatsu C9100-50 EMCCD camera, a Yokagawa Nipkow 
CSU10 scanner and a Zeiss Axio Observer. All the images were taken using the 40X (1.3NA) oil 
objective. Similar settings were used to collect compared genotypes and conditions.  
4.5.5 Quantifications 
To quantify axon degeneration, we scored the m12-Gal4, UAS-mCD8-GFP labeled axons 
within the segmental nerves according to one of the four categories between 0 to 3 (with 3 
meaning completely fragmented) (Figure 4.5). For each specific genotype and condition, more 
than 50 axons were quantified.  
To quantify the degeneration of NMJ, dissected larvae were stained for the MAP1B 
homologue Futsch and axonal membrane marker HRP. NMJs were scored to one of the three 
categories: complete degeneration (complete loss of Futsch staining and fragmentation of 
synaptic membrane), partial degeneration (partial loss of Futsch staining and partial 
fragmentation of synaptic membrane) and no degeneration (both Futsch and synaptic membrane 
are intact). For each specific genotype and condition, more than 20 NMJs from multiple animals 
were quantified. Percentages of NMJs in each category are shown.  
For puc-lacZ intensity quantification, the mean intensities for lacZ staining in the nuclei 
of motoneurons located along the dorsal midline of the larval nerve cord were measured using 
the Volocity software (Perkin Elmer). More than 6 animals were measured for each genotype 
and condition.  
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For measurement of Nmnat staining intensity in the neuropil, the neuropil area in each 
image was selected. We used auto-selection function of the Volocity software to select objects 
that meet the intensity criteria of >1 standard deviations above the mean within the neuropil 
region. The mean Nmant intensity was calculated by total intensity divided by total area in each 
animal. For each genotype, more than 5 animals were measured.  
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4.6 Figures 
Figure 4.1 
 
 
Figure 4.1 Wallerian degeneration of motoneuron and sensory neuron axons and synapses 
is strongly delayed in dcp-1
prev1
 animals. 
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(A) Single motoneuron axons in third instar larvae are labeled with membrane bound mCD8GFP 
with m12-Gal4 driver. In WT animals, axons that distal to the injury sites have completely 
fragmented within 20 hours after nerve crush injury. However, axons remain completely intact in 
dcp-1
prev1
 mutant background.  
(B) Quantification of the degree of axonal degeneration in different genotypes and different time 
points (See Figure 4.5A for scoring criteria). Black bars show the degeneration scores, whereas 
the white bars show the complementary intact scores.  
(C)  Representative images of muscle 4 NMJs in WT and dcp-1
prev1
 animals 20 hours after injury. 
In WT animals, the cytoskeleton marker Futsch (labeled as green) disappear from the NMJ, 
while the neuronal membrane (labeled with antibodies to HRP as red) become completely 
fragmented. In contrast, NMJs in the dcp-1
prev1
 animals show no sign of degeneration.  
(D) Quantification of NMJ degeneration. Black bars represent the percentage of NMJs that 
completely degenerated, grey bars represent percentage of NMJs that partially degenerated, and 
white bars represent the percentage of intact NMJs. The quantification criteria are described in 
Figure 4.5.  
(E) The axons and nerve terminals of class IV sensory neurons in larval ventral nerve cord are 
labeled by membrane bound mCD8GFP with the ppk-Gal4 driver. In WT animals, these 
structures are completely fragmented and cleared within 20 hours after injury (the remaining 
parts are the axons that haven’t been injured). However, these injured axons remain intact in dcp-
1
prev1
 animals.  
Scale bars=20µm , error bars represent SEM; **** represents p<0.0001 in t-test.  
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Figure 4.2 
 
 
Figure 4.2 The mutation that affects axonal degeneration is a loss-of-function mutation on 
gene raw. 
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(A) Representative images of muscle 4 NMJs 20 hours after injury in deficiency line BSC204  
(Df/+), deficiency and dcp-1
prev1
 heterozygous (Df/dcp-1
prev1
), raw mutants and dcp-1
prev1
 
heterozygous (raw
155.27
/ dcp-1
prev1
 and raw
134.47
/ dcp-1
prev1
). While NMJs have degenerated in 
Df/+, they are largely preserved in animals with the following genotypes, Df/dcp-1
prev1
, raw
155.27
/ 
dcp-1
prev1
 and raw
134.47
/ dcp-1
prev1
. Expression of UAS-Raw in raw
134.47
/ dcp-1
prev1
 background 
using a motoneuron driver D42-Gal4 significantly rescues the protective phenotype, whereas 
expression of UAS-Raw using a pan-glia driver repo-Gal4 fails to rescue.  
(B) Quantification of the degeneration of NMJs the genotypes shown in (A).  
(C) Schematic representation of the protein structure of Raw. It has a relatively large 
extracellular domain with a putative EF hand region labeled as green. dcp-1
prev1
 has a missense 
mutation within the EF hand. Both raw
134.47
 and raw
155.27
 has a missense mutation within the 
intracellular domain.  
(D) Expression of either Raw-RA or Raw-RB in raw
134.47
/ dcp-1
prev1
 background using a 
motoneuron driver m12-Gal4 rescues the protective effect of axon degeneration in raw
134.47
/ dcp-
1
prev1
 background animals. Moreover, depletion of Raw in motoneurons using raw-RNAi lines 
also strongly delays axonal degeneration.  
(E) Quantification of axonal degeneration of the animals with genotypes shown in (D).  
Scale bars=20µm, error bars represent SEM; **** represents p<0.0001 in t-test. 
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Figure 4.3 
 
 
Figure 4.3 Knockdown of nmnat modestly affects the protective effects of Raw. 
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(A) 20 hours after injury, axons in either raw
dcp-1
 animals or raw
dcp-1
 background with depletion 
of Nmnat in motoneuorns (raw
dcp-1
; m12-Gal4,UAS-nmnat-RNAi) remain intact.  
(B) Quantification of axonal degeneration in different time points for the noted genotypes. 
Comparing to WT animals (black line), knockdown of nmnat by RNAi (green line) modestly 
promotes axonal degeneration. While knockdown of nmnat in the hiw mutant background 
significantly rescues the axonal protection phenotype in hiw mutant (compare pink line to blue 
line), knockdown of nmnat in raw
dcp-1
 mutant background very modestly rescues the axonal 
protective effect of raw
dcp-1
 (compare red line to blue line).  
(C) Hiw up-regulates endogenous Nmnat level in neuropil (noted with yellow brackets), whereas 
Nmnat level is not affected in raw mutant (raw
dcp-1
).  
(D) Quantification of relative level of Nmnat in the neuropil regions of WT, hiw
ΔN
 and raw
dcp-1
 
animals.  
(E) Endogenous Nmnat level is up-regulated in glia that sheathing the segmental nerves in 
raw
dcp-1
 animals. Knockdown of nmnat using pan-glia driver repo-Gal4 can rescue the elevated 
Nmnat level in raw
dcp-1
 animals.  
(F) Knockdown of nmnat either in glia or in motoneuron fails to rescue the NMJ protective 
effects in raw
dcp-1
 animals.  
(G) Quantification of NMJ degeneration in different genotypes.  
Scale bar=20µm, error bars represent SEM; **** represents p<0.0001, ***= p<0.001, *=p<0.05, 
ns= not significant in t-test.  
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Figure 4.4 
 
 
 
Figure 4.4 Raw regulates axonal degeneration via transcription factor AP-1. 
(A) Comparing to uninjured WT animals, the puc-lacZ transcriptional reporter for JNK signaling 
is elevated in motoneurons depleted for Raw by expression of UAS-raw-RNAi using a pan-
neuronal driver BG380-Gal4. Nerve crush injury activates puc-lacZ reporter in WT animals, and 
in Raw depleted neurons, this reporter can be further activated by injury. (B) Quantification of 
relative puc-lacZ intensities (described in methods) in different genotypes. (C) Single 
motoneuron axons are labeled by membrane bound mCD8GFP. As shown in Figure 4.1, axonal 
degeneration is strongly delayed in raw
dcp-1
 animals. Expression of dominant negative form JNK 
(JNK
DN
) using motoneuron driver m12-Gal4 has very little effect axonal degeneration, whereas 
expression of Jun
DN
 or Fos
DN
 can partially rescue the protective effect in raw
dcp-1
 animals. (E) 
Quantification of axon degeneration scores in indicated genotypes. Scale bar=20µm, error bars 
represent SEM; **** represents p<0.0001, ***= p<0.001, ns= not significant in t-test. 
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Figure 4.5 
 
 
Figure 4.5 The quantification standards for axon degeneration and NMJ degeneration. 
(A) Axons  that are completely intact and smooth after injury are scored as 0. Axons that 
continuous but with varicosities are score as 1.  Axons that partially fragmented, but partially 
continuous are scored as 2. Axons that are completely fragmented are scored as 3.  
(B) NMJs that innervating larval muscle 4 are labeled by cytoskeleton marker Futsch (green) and 
HRP antibodies against neuronal membrane (red). Partial degeneration is defined by partially 
loss of Futsch and partially fragmentation of neuronal membrane. Completely degeneration is 
characterized by completely loss of Futsch in the NMJ and completely fragmentation of neuronal 
membrane.  
Scale bar=20µm 
 89 
 
Figure 4.6 
 
 
 
 
Figure 4.6 The axonal degeneration phenotype in dcp-1
prev1
 animals are not linked to the 
mutation on gene dcp-1. 
(A) Representative images of muscle 4 NMJs in dcp-1
2
, dcp-1
3
, k05606/dcp-1
prev1
 and one 
recombinant line (mutation on dcp-1 in dcp-1
prev
 + WT chromosome). At 20 hours after injury, 
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NMJs are completely degenerated in WT animals, but largely preserved in dcp-1
prev
 animals 
(Figure 4.1). The protective effects are not observed in all the genotypes shown here.  
(B) Quantifications of the percentages of NMJs that are completely degenerated, partially 
degenerated or intact for the genotypes shown.  
Scale bar=20µm 
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Table 4.1 
candidate genes 
(chromosome location) 
complementary deficiency line 
(deleted region) 
dcp-1
Prev1
/Df  axon degeneration 
phenotype? 
CG10874 (22D1) Df(2L)BSC688 (22B1-22D6) No 
Msp-300 (25C6-25C10) 
Df(2L)Exel6011 (25C8-25D5) No 
Df(2L)BSC109 (25C4-25C8) No 
Eya (26E1-26E2) Df(2L)BSC354 (26D7-26E3) No 
Raw (29E4-29E6) Df(2L)BSC204 (29D5-29F8) Yes 
CG9525 (29F5-29F6) 
Df(2L)BSC204 (29D5-29F8) No 
Df(2L)ED678 (29F5-30B12) No 
CG17211 (33D2) Df(2L)ED775 (33B8-34A3) No 
 
Table 4.1 complementation test for candidate genes with deficiencies.  
Small deficiencies that have the candidate genes deleted were crossed with  dcp-1
prev1
 animals. 
Heterozygous df/ dcp-1
prev1
 animals were injured and tested for NMJ degeneration phenotype. 
Only the deficiency line that has gene raw deleted recapitulated the NMJ protective phenotype in 
homozygous dcp-1
prev1
 animals, suggesting the mutation on gene raw causes the axonal 
protective phenotype.  
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Chapter 5 :  
Discussion and future directions 
 
Neurons need to maintain their function for a lifetime once they are mature. Therefore the 
ability to cope with stress and environmental insults is fundamental. Neurons are also unique 
because of their highly polarized structure (axons and dendrites) for information transmission. 
Axons connect neurons over long distances in the brain and body, and thus are vulnerable to 
damage and injury. In some cases damaged axons can initiate new growth and reconnect with 
their targets. However in many cases, including in the mammalian central nervous system (CNS), 
damaged axons fail to regrow and the disconnected neurons undergo cell death. Although it is 
now widely acknowledged that both intrinsic and extrinsic factors contribute to axonal 
regenerative capacity, the molecular mechanisms that regulate axonal regeneration are still not 
fully understood. For neurons that can regenerate axons after injury, a series of responses are 
involved. These include retrograde transport of injury signaling molecules, large scale 
transcriptional responses, initiation of new axonal growth from the proximal axonal stumps, and 
degeneration and clearance of the disconnected distal axonal stumps to clear the path for axonal 
regeneration. In this thesis, I used Drosophila as a model organism to study the molecular and 
cellular mechanisms of these processes. I have described new mechanisms for both axonal 
regeneration and axonal degeneration. Some of my studies have extended from Drosophila to the 
mammalian nervous system, suggesting the regulatory mechanisms are highly evolutionarily 
conserved. While these studies have enriched our understanding of the axonal injury response, 
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they also lead to new questions. In this chapter, I will focus on summarizing and discussing my 
current findings as well as future research directions.  
5.1 Wnd/DLK ‘senses’ axonal damage via cAMP/PKA 
In order to promote new axonal growth after injury, neurons respond to axonal injury by 
initiating a large-scale transcriptional responses. However, in most cases, the axonal injury site is 
far away from the cell body. Then how does the cell body ‘know’ that a distant site in the axon is 
injured? Previous work from our lab and others have identified the conserved axonal MAPKKK 
Wnd/DLK, which appears to function as an acute ‘sensor’ of axonal damage and mediate a 
retrograde injury signaling in neurons (Xiong et al., 2010, Hammarlund et al., 2009, Yan et al., 
2009, Holland et al., 2016). The levels of this protein appear to be tightly regulated in axons (via 
a post-transcriptional mechanism), and rise within hours in damaged axons (Xiong et al., 2010, 
Huntwork-Rodriguez et al., 2013). Wnd/DLK is required for axonal regeneration in many types 
neurons in the PNS. Conversely, in mammalian CNS neurons that do not regenerate, DLK 
activation after injury mediates cell death (Watkins et al., 2013, Welsbie et al., 2013). The 
dramatic and dichotomous outcomes of DLK have attracted great recent interest in understanding 
how this kinase is regulated. My studies in Chapter 3 have identified cAMP/PKA as a direct 
upstream activator of DLK in the context of axonal regeneration after acute axonal injury. 
Although the activation loop of DLK is known to be critical for DLK’s function, my study 
provided the first evidence that it is directly phosphorylated and activated by a highly 
evolutionarily conserved kinase PKA. Importantly, cAMP has been previously demonstrated to 
play a central role in axon regeneration: up-regulation of cAMP level is sufficient to enhance 
axon regeneration in both the PNS and CNS (Cai et al., 1999, Neumann and Woolf, 1999, Cai et 
al., 2001, Qiu et al., 2002). Therefore, my study has unified two important regeneration signaling 
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pathways by providing a direct molecular link, suggesting that axonal regeneration is regulated 
in one common signaling pathway. However, this novel signaling pathway is still not fully 
understood. For example, it is not clear that how this pathway is activated and whether it has 
other functional implications. I this section, I will discuss these outstanding questions derived 
from my studies.  
5.1.1 Does PKA activate DLK in other contexts? 
As discussed above, DLK is not only activated during axonal regeneration, it is also 
activated in other contexts, including nerve growth factor (NGF) withdrawal induced DRG 
neuron death (Huntwork-Rodriguez et al., 2013) and retinal ganglion cell (RGC) death in 
glaucoma model (Welsbie et al., 2013). Moreover, a recent unpublished study suggest that DLK 
is also activated in Amyotrophic lateral sclerosis (ALS) models. It would be interesting to test 
whether PKA mediates DLK’s activation in these models. Although I found that PKA directly 
phosphorylates DLK at its activation loop (which is critical for DLK to function as a kinase), I 
cannot exclude the possibility that the activation loop can also be phosphorylated by other 
kinases. Therefore, it is entirely possible that DLK is activated via different mechanisms in 
different models. Indeed, a recent study in Drosophila suggested that mTORC1 also 
phosphorylates DLK at its activation loop in mediating synaptic growth (Wong et al., 2015). My 
data suggest that PKA regulates DLK independently of mTORC1 (Figure 3.7). 
5.1.2 How does PKA stabilize DLK? 
DLK protein level strongly correlates with DLK activation and function. Axonal injury 
stabilizes DLK protein in axons and activates its downstream signaling (Huntwork-Rodriguez et 
al., 2013, Xiong et al., 2010). In cultured DRG neurons, NGF withdrawal also promotes DLK 
level and activates DLK signaling (Huntwork-Rodriguez et al., 2013).  Moreover, increased 
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DLK level is sufficient to activate the DLK signaling pathway (Mata et al., 1996, Huntwork-
Rodriguez et al., 2013). Therefore, understanding how DLK level is regulated is of great interest. 
Previous study suggested that DLK level can be stabilized via a feedback mechanism through 
which a downstream kinase JNK directly phosphorylated DLK outside of its activation loop 
(Huntwork-Rodriguez et al., 2013).  My findings described in Chapter 3 suggests that activation 
of PKA also stabilizes DLK (Figure 3.4). Interestingly, further studies demonstrated that PKA 
stabilizes DLK via a mechanism that is independent of the phosphorylation of DLK’s activation 
loop or the phosphorylation of DLK mediated by JNK (Figure 3.4). However, it is not clear that 
how PKA stabilizes DLK. 
A recent study suggests that DLK is also palmitoylated and palmitoylation is important 
for DLK’s function (Holland et al., 2016). I therefore wonder whether PKA stabilizes DLK in a 
palmitoylation dependent manner. Since DLK is palmitoylated in HEK293 cells (Holland et al., 
2016), I tested this idea by expressing a mutant DLK with the palmitoylation site mutated in 
HEK293 cells. I found that either Forskolin treatment or PKA co-expression can stabilize the 
non-palmitoylation DLK mutant (Figure 5.1A and B). Therefore, I conclude that PKA stabilizes 
DLK independent of DLK palmitoylation.  
In seeking to understand the mechanisms by which PKA regulates DLK, we have 
performed a proteomic analysis of DLK upon PKA transfection or forskolin treatment. In this 
study, we have identified several putative PKA phosphorylation sites (Figure 5.2). Therefore, it 
is possible that phosphorylation of DLK by PKA at sites other than S302 stabilizes DLK. Indeed, 
some of the potential sites, such as S584 and S640, are located within PKA consensus sequences 
(discussed in Chapter 3).  
 96 
 
Moreover, previous studies suggest that DLK level is tightly regulated through the 
ubiquitin proteasome system (UPS) (Huntwork-Rodriguez et al., 2013, Nakata et al., 2005). 
Therefore, it is also possible that PKA regulates DLK stability indirectly through modulation of 
the UPS. This possibility can be tested in cultured cells by either pharmacologically inhibiting 
the proteasome or  manipulating DLK ubiquitination through expression of the de-ubiqutinating 
enzyme USP9X.  
5.1.3 Does cAMP level elevation correlate with axon regeneration and DLK activation? 
A central feature of axonal regeneration is that axons can regenerate after injuries in the 
PNS, but generally fail to re-grow after injuries in the CNS. Studies have been focusing on 
understanding the differences in underlying molecular mechanisms between the CNS and the 
PNS in response to axonal injuries. Previous studies demonstrated that DLK protein level is 
stabilized by axonal injury in both the PNS (sciatic nerve injury model) and the CNS (optical 
nerve injury model)(Xiong et al., 2010, Huntwork-Rodriguez et al., 2013, Watkins et al., 2013, 
Shin et al., 2012a), suggesting that DLK’s activation is not always associated with axonal 
regeneration. Instead, activation of DLK in the CNS promotes cell death (Watkins et al., 2013, 
Welsbie et al., 2013). Therefore, understanding the mechanisms of DLK activation in the PNS 
and the CNS after axonal injury is of great interest.  
It has been documented that after sciatic nerve crush injury in mice, cAMP level 
increases two-fold within 24 hours in DRG neurons, and this effect is correlated with enhanced 
axonal re-growth capacity (Qiu et al., 2002). My study in Chapter 3 suggested that increased 
cAMP level in the PNS is responsible for the activation of DLK and through which axonal 
regeneration is stimulated. I therefore wonder whether that is the mechanism specific for axonal 
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regeneration in the PNS, but not the CNS, which could potentially explain the different outcomes. 
However, it is not clear whether  cAMP level changes after axonal injury in the CNS.   
As I have discussed in Chapter 2, Drosophila nervous system also share the CNS and 
PNS dichotomy in axonal regeneration. Therefore, this hypothesis can be pursued using 
Drosophila as a model. An attractive approach would be utilizing genetic encoded sensors of 
cAMP levels in live neurons, in combination with laser axotomy and live imaging techniques.  
5.1.4 Which adenylyl cyclase (AC) is required for regulating cAMP level after injury? 
Intracellular cAMP level in tightly controlled by adenylyl cyclases (ACs), which catalyze 
the conversion of ATP to cAMP. As there are several different types of ACs in neurons, 
identifying the specific type of AC that regulates injury induced cAMP change would shed light 
on our understanding of injury signaling. There are totally 13 AC genes in Drosophila genome. 
One could test which AC is required for the cAMP or Wnd level changes in axons after axotomy 
by using RNAi mediated knock-down for each of them.  
It is well documented that in both cultured neurons in vitro and live animals in vivo that 
intra-axonal calcium level increases within seconds after axotomy (Adalbert et al., 2012, Wolf et 
al., 2001, Avery et al., 2012). Moreover, studies in C.elegans suggested that calcium promotes 
axon regeneration in a DLK dependent manner (Ghosh-Roy et al., 2010, Yan and Jin, 2012). 
Since some ACs are directly modulated by calcium, a logical hypothesis is that a Ca2+-sensitive 
AC connects axotomy to cAMP changes. In Drosophila genome, the gene called rutabaga is 
identified as the single homolog of calcium-sensitive AC. Therefore, Rutabaga is an interesting 
candidate to test.  
 98 
 
5.1.5 Are A-Kinase Anchoring Proteins (AKAPs) involved in mediating axonal injury 
induced Wnd/DLK activation? 
AKAPs are regulators of cAMP-PKA signaling. AKAPs have the ability to form multi-
protein complexes allowing for a coordination of different enzymes affecting the spatial and 
temporal aspects of the signaling (Wong and Scott, 2004, Dell'Acqua et al., 2006). It would be 
interesting to know that whether AKAPs play a role in the regulation of DLK/Wnd by forming a 
stabilizing complex when PKA activates DLK/Wnd. Since Wnd protein becomes rapidly up-
regulated in axons after axonal injury, an axonally localized AKAP scaffold could provide an 
attractive mechanism for its induction in injured axons. 
There are 5 conserved AKAPs in Drosophila: Nervy, Spoonbill, Rugose (Akap550), 
Akap200 and Pkaap (Han et al., 1997, Lu et al., 2007, Jackson and Berg, 2002, Shamloula et al., 
2002, Terman and Kolodkin, 2004). In order to test the role of AKAPs in Wnd’s induction after 
injury, we can knockdown individual AKAPs using RNAi lines in Drosophila larvae in vivo. 
Since Wnd protein becomes induced after axon injury, one can compare the relative levels of 
Wnd within motoneurons lacking individual AKAPs to wild-type controls at time points before 
and after injury. One can also examine whether AKAP knockdown affects the activation of the 
puckered reporter (puc-lacZ), which is a downstream reporter for Wnd signaling. The 
information obtained from these experiments would give insight into mechanisms through which 
Wnd/DLK is regulated.  
5.1.6 Does Hiw regulate Wnd/DLK via modulating cAMP level? 
As I have discussed in Chapter 1, the E3 ubiquitin ligase Hiw serves as an important 
regulator of Wnd in many circumstances. One study in C. elegans suggested that Hiw’s 
homologue Rpm-1 down-regulates DLK by directly promoting its ubiquitination (Nakata et al., 
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2005). Nakata et al. compared the ubiquitin levels of immunoprecipitated Flag-tagged DLK from 
HA-ubiquitin, HA-Rpm-1 and Flag-DLK co-transfected HEK cells to that from HA-ubiquitin 
and Flag-DLK co-transfected cells by probing the western blot with HA antibody. They showed 
that the immunoprecipitated DLK from the cells that co-transfected with HA-Rpm-1 has higher 
level of co-immunoprecipitated HA-ubiquitin. However, the increased HA antibody signal could 
be co-immunoprecitated HA-Rpm-1. Therefore the data for such direct regulation in vivo is not 
satisfying and ubiquitination could not be the only mechanism that Hiw regulates Wnd/DLK.  
Intriguingly, a previous study suggested that Hiw contains a RCC-1 like domain that can 
biochemically inhibit ACs and therefore negatively regulate cAMP level (Pierre et al., 2004). 
Since the relationship between cAMP and DLK has been established, it is possible that Hiw 
regulates Wnd/DLK through cAMP (this model is depicted in Figure 5.3). An interesting future 
direction would be to test whether Hiw regulates cAMP levels at presynaptic terminals, where it 
localizes, and whether this regulation mediates Hiw’s regulation of Wnd.  
5.2 PKA regulates Wallerian degeneration via Wnd 
Previous studies from our lab and others have suggested that Wnd/DLK signaling can 
influence Wallerian degeneration (Xiong and Collins, 2012, Miller et al., 2009, Yang et al., 
2015). Since PKA functions upstream of Wnd/DLK, I wonder whether PKA regulates Wallerian 
degeneration. To test this, I expressed membrane-bound mCD8GFP using the motoneuron driver 
m12-Gal4, which labels single axons in Drosophila. I found that overexpression of the 
constitutively active form of PKA (PKA
CA
) strongly protected axons from degeneration after 
nerve crush injury (Figure 5.4). Furthermore, knockdown of Wnd using RNAi can partially 
rescue the protective effects of PKA (Figure 5.4).  There are two possible reasons that can 
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explain why wnd-RNAi cannot completely rescue the phenotype. First, wnd-RNAi may only 
partially disrupt Wnd expression in neurons. Alternatively,  PKA may influence Wallerian 
degeneration via additional mechanisms that are independent of Wnd.  
While cAMP and PKA are known for their important roles in axonal regeneration, here I 
report for the first time that PKA also regulates axonal degeneration. As Nmnat has been thought 
as a central regulator of axon degeneration, I wondered whether Nmnat level changed when 
PKA
CA
 was expressed in neurons. To test this, I co-expressed UAS-nmnat-RFP in neurons. 
However, I found overexpressed Nmnat level was not affected by PKA (Figure 5.5). In the future, 
it would interesting to test whether knockdown of nmnat rescues the axonal protective effect 
mediated by PKA.  
5.3 PKA regulates mitochondrial morphology via Wnd 
Mitochondria are highly dynamic organelles which play important roles including ATP 
generation, biosynthesis, calcium buffering and apoptotic signaling. In neurons, mitochondria are 
transported into axons to maintain normal axonal function. Mitochondrial fission and fusion are 
dynamic are critical for mitochondrial transport, mitophagy, apoptosis and necrosis (Shutt and 
McBride, 2013, Sheridan and Martin, 2010, Wang et al., 2012b). Deficiency in mitochondrial 
fission and fusion machinery is associated with a broad array of neurodegenerative diseases 
(Reilly et al., 2011, Waterham et al., 2007, Ishihara et al., 2009). Therefore, understanding of the 
regulatory machinery of mitochondrial fission and fusion in neurons is of great importance.  
  I have found that expression of PKA
CA
 in neurons induced elongated mitochondria in 
axons (Figure 5.4A and B). This finding is consistent with a previous study which suggests that 
PKA regulates mitochondrial elongation in cultured neurons (Merrill et al., 2011). Moreover, I 
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found that this effect is Wnd dependent, as knockdown of Wnd by wnd-RNAi rescues the 
elongated mitochondrial phenotype (Figure 5.6A and B). These findings suggest that PKA 
functions upstream of Wnd/DLK in regulating mitochondrial morphology. In the future, it would 
be interesting to study the functional consequences of these elongated mitochondria. For 
example, one could investigate whether they play a role in axonal regeneration and degeneration.  
5.4 PKA regulates synaptic morphology during development via Wnd  
Normal synaptic growth during development is essential for the nervous system to 
mediate complex behavior such as learning and memory. The Drosophila NMJ has been 
demonstrated as a powerful system to study the underlying molecular mechanisms of synaptic 
development and plasticity (Collins and DiAntonio, 2007). Since both PKA and Wnd have been 
previously suggested to function in regulating synaptic growth in Drosophila (Yoshihara et al., 
2005, Chen and Ganetzky, 2012, Collins et al., 2006), I wondered whether they function in a 
common signaling pathway to regulate synaptic development. To test this, I expressed membrane 
bound mCD8GFP in motoneurons using m12-Gal4 driver and observed the morphology of NMJs 
that innervating muscle 12. I found that expression of PKA
CA
 or Wnd alone induced filopodia-
like structures along the boutons (Figure 5.7). Moreover, the effect of PKA
CA
 on synaptic 
morphology is Wnd dependent as knockdown of Wnd rescued this phenotype, whereas 
expression of control RNAi (moody-RNAi) failed to rescue (Figure 5.7). This finding suggested 
that PKA functions upstream of Wnd to regulate synaptic morphology during development. 
Previous studies suggested that PKA signaling is required for synaptic plasticity in memory and 
learning (reviewed by (Lee, 2015)), my finding here suggested an intriguing possibility that 
Wnd/DLK might also contribute to these mechanisms.  
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5.5 Figures 
Figure 5.1 
 
 
Figure 5.1 PKA regulates DLK stability independent of DLK palmitoylation. 
(A) HEK293 cells were either transfected with WT DLK or DLK-C127S, a point mutation that 
prevents DLK from palmitoylation. Treatment with Forskolin stabilizes both WT DLK and 
DLK-C127S.  
(B) Co-transfection of PKA
CA
 either with WT DLK or DLK-C127S stabilizes their levels in 
HEK293 cells. Moreover, phosphorylation of Ser302 was strongly reduced in DLK-C127S 
mutant.  
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Figure 5.2 
 
 
Figure 5.2 proteomic analysis on DLK upon Forskolin treatment or PKA co-transfection. 
HEK 293 cells were transfected with Flag-DLK alone (either treated with control vehicle or 
Forskolin) or transfected with both Flag-DLK and PKA. Flag-DLK was immunoprecipitated by 
anti-Flag antibodies. 5 µg purified (via SDS-PAGE gel) DLK from each group was subjected to 
mass spec analysis. Spectral count for each identified site in each experiment group were plotted 
in the graph.  
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Figure 5.3 
 
 
Figure 5.3 Proposed model of the mechanisms for regulation of Wnd/DLK by Hiw. 
Previous studies suggested that Hiw down-regulates Wnd/DLK level through promoting its 
ubiquitination. Here I propose that hiw might regulate Wnd/DLK via an alternative mechanism 
by which Hiw modulates cAMP level via its RCC-1 domain.  
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Figure 5.4 
 
 
 
Figure 5.4 PKA regulates Wallerian degeneration via Wnd. 
Expression of PKA
CA
 in motoneurons strongly suppressed axon degeneration after nerve crush 
assay comparing to WT axons. Co-expression of wnd-RNAi with PKA
CA
 can partially rescue 
axon degeneration, whereas co-expression of a control RNAi cannot.  
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Figure 5.5 
 
 
 
Figure 5.5 Nmnat level does not change significantly when PKA
CA
 is expressed in neurons. 
HA-tagged Nmnat is expressed in motoneurons using m12-Gal4 driver. Ectopically expression 
of PKA
CA
 does not significantly change Nmnat level in axons. ns, not significant. 
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Figure 5.6 
 
 
 
 
Figure 5.6 PKA promotes elongated mitochondria in axons via Wnd. 
(A) Overexpression of PKA
CA
 induces elongated mitochondria in motoneuron axons. This 
phenotype is Wnd dependent as knockdown of Wnd rescues this phenotype.  
(B) In each genotype, mitochondria were grouped based their length. The proportion of 
mitochondria in each group was quantified.  
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Figure 5.7 
 
 
 
 
Figure 5.7 PKA regulates synaptic morphology via Wnd. 
Overexpression of PKA
CA
 or Wnd in motoneurons induced filopodia-like protrusions on the 
bontons of NMJ.  The phenotype caused by PKA
CA
 is Wnd dependent as knockdown of Wnd 
completely rescues this phenotype, whereas it cannot be rescued by a control RNAi.    
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